Full Transcript Introduction to Long COVID Comorbidities 0:02 One of the problems that we see with not 0:02 One of the problems that we see with not all, but some specialty clinics is they 0:04 all, but some specialty clinics is they 0:04 all, but some specialty clinics is they may even run the tests, but they'll find 0:06 may even run the tests, but they'll find 0:06 may even run the tests, but they'll find positives and say, "Well, that's normal 0:08 positives and say, "Well, that's normal 0:08 positives and say, "Well, that's normal for people." It's not normal if you're 0:10 for people." It's not normal if you're 0:10 for people." It's not normal if you're sick and not getting better to have 0:12 sick and not getting better to have 0:12 sick and not getting better to have those things be positive.
Channel Intro and Long COVID Overview 0:18 Welcome to the channel. I'm Dr. A. I've 0:18 Welcome to the channel. I'm Dr. A. I've been researching and teaching in the 0:19 been researching and teaching in the 0:20 been researching and teaching in the integrative and naturopathic communities 0:21 integrative and naturopathic communities 0:21 integrative and naturopathic communities for 30 plus years now and seeing 0:24 for 30 plus years now and seeing 0:24 for 30 plus years now and seeing patients a long time in the chronic 0:25 patients a long time in the chronic 0:25 patients a long time in the chronic illness space and I use this channel to 0:28 illness space and I use this channel to 0:28 illness space and I use this channel to answer questions about those topics. 0:30 answer questions about those topics. 0:30 answer questions about those topics. Long COVID recovery and why is it taking 0:33 Long COVID recovery and why is it taking 0:33 Long COVID recovery and why is it taking so long? It seems like a glacier trying 0:35 so long? It seems like a glacier trying 0:35 so long? It seems like a glacier trying to heal. Well, there's a number of 0:37 to heal. Well, there's a number of 0:37 to heal. Well, there's a number of reasons, but the first thing is that 0:39 reasons, but the first thing is that 0:39 reasons, but the first thing is that long COVID is a constellation of signs 0:43 long COVID is a constellation of signs 0:43 long COVID is a constellation of signs and symptoms that are different amongst 0:46 and symptoms that are different amongst 0:46 and symptoms that are different amongst different people, but what is in common 0:49 different people, but what is in common 0:49 different people, but what is in common with them is they have COVID in the 0:51 with them is they have COVID in the 0:51 with them is they have COVID in the background and at some point after they 0:55 background and at some point after they 0:55 background and at some point after they recovered from the acute COVID 0:57 recovered from the acute COVID 0:57 recovered from the acute COVID infection, they wound up with something 1:00 infection, they wound up with something 1:00 infection, they wound up with something in the neighborhood of a chronically 1:02 in the neighborhood of a chronically 1:02 in the neighborhood of a chronically fatiguing illness, possibly brain fog, 1:06 fatiguing illness, possibly brain fog, 1:06 fatiguing illness, possibly brain fog, possibly chronic pain that comes up, 1:09 possibly chronic pain that comes up, 1:09 possibly chronic pain that comes up, possibly organ dysfunction, possibly 1:12 possibly organ dysfunction, possibly 1:12 possibly organ dysfunction, possibly endocrine dysfunction, and on and on. 1:15 endocrine dysfunction, and on and on. 1:15 endocrine dysfunction, and on and on. There's many different lists that you 1:16 There's many different lists that you 1:16 There's many different lists that you can look up about long COVID, but it's 1:18 can look up about long COVID, but it's 1:18 can look up about long COVID, but it's basically a bodywide fatiguing illness. 1:22 basically a bodywide fatiguing illness. 1:22 basically a bodywide fatiguing illness. So, one of the biggest reasons why 1:25 So, one of the biggest reasons why 1:25 So, one of the biggest reasons why people have a long, protracted
Why Recovery Takes So Long 1:29 people have a long, protracted 1:29 people have a long, protracted recovery from long COVID is the parts 1:32 recovery from long COVID is the parts 1:32 recovery from long COVID is the parts that sometimes, now not always, but 1:35 that sometimes, now not always, but 1:35 that sometimes, now not always, but sometimes these other parts that we call 1:37 sometimes these other parts that we call 1:37 sometimes these other parts that we call comorbidities are not looked at. And so, 1:40 comorbidities are not looked at. And so, 1:40 comorbidities are not looked at. And so, what I want to do in this brief video is 1:42 what I want to do in this brief video is 1:42 what I want to do in this brief video is tell you what those comorbidities are.
Endocrine and Hormonal Issues 1:45 tell you what those comorbidities are. 1:45 tell you what those comorbidities are. These are very worth looking at in 1:47 These are very worth looking at in 1:47 These are very worth looking at in regard to testing. And then, as another 1:49 regard to testing. And then, as another 1:49 regard to testing. And then, as another commenter brought up last week on one of 1:51 commenter brought up last week on one of 1:51 commenter brought up last week on one of the videos, it's not just about testing. 1:54 the videos, it's not just about testing. 1:54 the videos, it's not just about testing. Someone commented, they say, "Oh yeah, 1:55 Someone commented, they say, "Oh yeah, 1:55 Someone commented, they say, "Oh yeah, test, test, test, and then don't do 1:57 test, test, test, and then don't do 1:57 test, test, test, and then don't do anything for me." I'm sorry that that 1:59 anything for me." I'm sorry that that 1:59 anything for me." I'm sorry that that happened some places in medicine, but 2:01 happened some places in medicine, but 2:01 happened some places in medicine, but that's not what we do. So, what you need 2:03 that's not what we do. So, what you need 2:03 that's not what we do. So, what you need to do is you need to get these things 2:05 to do is you need to get these things 2:05 to do is you need to get these things assessed and tested, and then you need 2:07 assessed and tested, and then you need 2:07 assessed and tested, and then you need to find the practitioners actually going 2:09 to find the practitioners actually going 2:09 to find the practitioners actually going to do something about them so that it 2:11 to do something about them so that it 2:11 to do something about them so that it will help speed up the recovery process. 2:14 will help speed up the recovery process. 2:14 will help speed up the recovery process. And these don't go in any particular 2:16 And these don't go in any particular 2:16 And these don't go in any particular order, but the first thing is your 2:18 order, but the first thing is your 2:18 order, but the first thing is your endocrine system. The most common areas 2:20 endocrine system. The most common areas 2:20 endocrine system. The most common areas we see in long COVID patients endocrine 2:23 we see in long COVID patients endocrine 2:23 we see in long COVID patients endocrine is hormonal. Those can be things such as 2:26 is hormonal. Those can be things such as 2:26 is hormonal. Those can be things such as thyroid deficiency or resistance, so 2:30 thyroid deficiency or resistance, so 2:30 thyroid deficiency or resistance, so that needs to be tested for. Again, we 2:32 that needs to be tested for. Again, we 2:32 that needs to be tested for. Again, we have longer form content on that. You 2:34 have longer form content on that. You 2:34 have longer form content on that. You can get derangements in your 2:35 can get derangements in your 2:35 can get derangements in your reproductive hormones, male or female. 2:38 reproductive hormones, male or female. 2:38 reproductive hormones, male or female. That can be decrease in testosterone, 2:41 That can be decrease in testosterone, 2:41 That can be decrease in testosterone, men or women, increase in estrogen, 2:43 men or women, increase in estrogen, 2:43 men or women, increase in estrogen, which can create problems in males or 2:45 which can create problems in males or 2:45 which can create problems in males or females, and any number of other things 2:48 females, and any number of other things 2:48 females, and any number of other things that go on there. So, checking the 2:50 that go on there. So, checking the 2:50 that go on there. So, checking the endocrine system is critically important 2:52 endocrine system is critically important 2:52 endocrine system is critically important because if your thyroid has become 2:54 because if your thyroid has become 2:54 because if your thyroid has become resistant or slowed down, and it wasn't 2:57 resistant or slowed down, and it wasn't 2:57 resistant or slowed down, and it wasn't a problem before COVID, sometimes they 2:58 a problem before COVID, sometimes they 2:58 a problem before COVID, sometimes they won't check it when you have long COVID. 3:00 won't check it when you have long COVID. 3:00 won't check it when you have long COVID. But if your thyroid slowed down because 3:02 But if your thyroid slowed down because 3:02 But if your thyroid slowed down because you have long COVID, you have to treat 3:04 you have long COVID, you have to treat 3:04 you have long COVID, you have to treat that to help you pull out of the 3:06 that to help you pull out of the 3:06 that to help you pull out of the problem. The next would be toxic
Toxic Exposures and Environmental Sensitivities 3:08 problem. The next would be toxic 3:08 problem. The next would be toxic influences. I've seen people become very 3:11 influences. I've seen people become very 3:11 influences. I've seen people become very sensitive to mold mycotoxins in the 3:15 sensitive to mold mycotoxins in the 3:15 sensitive to mold mycotoxins in the environment that weren't sensitive 3:16 environment that weren't sensitive 3:16 environment that weren't sensitive before they had COVID. I've seen people 3:18 before they had COVID. I've seen people 3:18 before they had COVID. I've seen people who have exposures, ongoing exposures to 3:21 who have exposures, ongoing exposures to 3:21 who have exposures, ongoing exposures to metals or chemicals. All of these things 3:23 metals or chemicals. All of these things 3:24 metals or chemicals. All of these things can be assessed. Are the tests perfect? 3:26 can be assessed. Are the tests perfect? 3:26 can be assessed. Are the tests perfect? No, they're not perfect, but it should 3:27 No, they're not perfect, but it should 3:27 No, they're not perfect, but it should be something if your case is not getting 3:29 be something if your case is not getting 3:29 be something if your case is not getting better that you maybe find somebody who 3:31 better that you maybe find somebody who 3:31 better that you maybe find somebody who does environmental medicine to look into 3:34 does environmental medicine to look into 3:34 does environmental medicine to look into toxicities. And again, it can be 3:36 toxicities. And again, it can be 3:36 toxicities. And again, it can be environmental things like mold 3:38 environmental things like mold 3:38 environmental things like mold mycotoxins, other biotoxin illness, 3:40 mycotoxins, other biotoxin illness, 3:41 mycotoxins, other biotoxin illness, chemicals, or metals that go on, and you 3:43 chemicals, or metals that go on, and you 3:43 chemicals, or metals that go on, and you weren't sensitive before COVID, but now 3:46 weren't sensitive before COVID, but now 3:46 weren't sensitive before COVID, but now you are after. Quick interruption from 3:48 you are after. Quick interruption from 3:48 you are after. Quick interruption from the regular video. If you are a 3:50 the regular video. If you are a 3:50 the regular video. If you are a healthcare practitioner and you have an 3:51 healthcare practitioner and you have an 3:51 healthcare practitioner and you have an interest in this topic, we're going to 3:53 interest in this topic, we're going to 3:53 interest in this topic, we're going to put a link in the description below to 3:55 put a link in the description below to 3:55 put a link in the description below to my CE website, and specifically the 3:58 my CE website, and specifically the 3:58 my CE website, and specifically the webinar that is about this topic. So, 4:00 webinar that is about this topic. So, 4:00 webinar that is about this topic. So, see you over there. Thanks. The next 4:02 see you over there. Thanks. The next 4:02 see you over there. Thanks. The next area would be infectious {slash} 4:05 area would be infectious {slash} 4:05 area would be infectious {slash} autoimmune, two areas of the immune
Infections and Autoimmune Triggers 4:08 autoimmune, two areas of the immune 4:08 autoimmune, two areas of the immune system. So, in the autoimmune area, we 4:11 system. So, in the autoimmune area, we 4:11 system. So, in the autoimmune area, we know by research now that people during 4:14 know by research now that people during 4:14 know by research now that people during and after COVID infection have developed 4:17 and after COVID infection have developed 4:17 and after COVID infection have developed positive antinuclear antibodies that 4:20 positive antinuclear antibodies that 4:20 positive antinuclear antibodies that indicate autoimmunity, positive thyroid 4:23 indicate autoimmunity, positive thyroid 4:23 indicate autoimmunity, positive thyroid antibodies, positive other 4:25 antibodies, positive other 4:25 antibodies, positive other autoantibodies. The bottom line there is 4:26 autoantibodies. The bottom line there is 4:26 autoantibodies. The bottom line there is maybe you didn't have it before, and it 4:28 maybe you didn't have it before, and it 4:28 maybe you didn't have it before, and it was never tested, but you have long 4:30 was never tested, but you have long 4:30 was never tested, but you have long COVID, you're not getting better. This 4:32 COVID, you're not getting better. This 4:32 COVID, you're not getting better. This is something that should be looked at. 4:33 is something that should be looked at. 4:33 is something that should be looked at. What we do in people, regardless of 4:35 What we do in people, regardless of 4:35 What we do in people, regardless of their history, they didn't have them, 4:37 their history, they didn't have them, 4:37 their history, they didn't have them, did have them, whatever, we will screen 4:39 did have them, whatever, we will screen 4:39 did have them, whatever, we will screen the autoimmune markers, generally the 4:42 the autoimmune markers, generally the 4:42 the autoimmune markers, generally the ANA family, which you if it's positive, 4:45 ANA family, which you if it's positive, 4:45 ANA family, which you if it's positive, they can do the other tests, the 4:47 they can do the other tests, the 4:47 they can do the other tests, the rheumatic autoimmune families, the 4:49 rheumatic autoimmune families, the 4:49 rheumatic autoimmune families, the thyroid autoimmune families, and just 4:51 thyroid autoimmune families, and just 4:51 thyroid autoimmune families, and just look at them broadly, very, very 4:53 look at them broadly, very, very 4:53 look at them broadly, very, very critical, because if you have now a 4:55 critical, because if you have now a 4:55 critical, because if you have now a comorbid autoimmunity that you didn't 4:57 comorbid autoimmunity that you didn't 4:58 comorbid autoimmunity that you didn't used to have, that can be another 4:59 used to have, that can be another 4:59 used to have, that can be another explanation for why you're not getting 5:01 explanation for why you're not getting 5:01 explanation for why you're not getting better. The other infectious end of the 5:03 better. The other infectious end of the 5:03 better. The other infectious end of the immune system, and we know now lots of 5:06 immune system, and we know now lots of 5:06 immune system, and we know now lots of people, so almost 100% of your humanity 5:09 people, so almost 100% of your humanity 5:09 people, so almost 100% of your humanity by the age of 20 is exposed to chronic 5:12 by the age of 20 is exposed to chronic 5:12 by the age of 20 is exposed to chronic viral things like Epstein-Barr and other 5:14 viral things like Epstein-Barr and other 5:14 viral things like Epstein-Barr and other stuff. What we see in the research is 5:16 stuff. What we see in the research is 5:16 stuff. What we see in the research is that COVID has a way of unmasking these 5:19 that COVID has a way of unmasking these 5:19 that COVID has a way of unmasking these and reactivating them. So, again, if 5:21 and reactivating them. So, again, if 5:21 and reactivating them. So, again, if you're fatigued, you got headaches, you 5:22 you're fatigued, you got headaches, you 5:22 you're fatigued, you got headaches, you got other stuff like that, and nobody 5:24 got other stuff like that, and nobody 5:24 got other stuff like that, and nobody has checked for chronic Epstein-Barr 5:26 has checked for chronic Epstein-Barr 5:26 has checked for chronic Epstein-Barr infection, the other things that we 5:28 infection, the other things that we 5:28 infection, the other things that we check for other chronic infections, 5:30 check for other chronic infections, 5:30 check for other chronic infections, Mycoplasma pneumoniae is very common, 5:33 Mycoplasma pneumoniae is very common, 5:33 Mycoplasma pneumoniae is very common, Chlamydia pneumoniae, that's the one for 5:35 Chlamydia pneumoniae, that's the one for 5:35 Chlamydia pneumoniae, that's the one for the lungs, not the other one, and then 5:37 the lungs, not the other one, and then 5:37 the lungs, not the other one, and then we generally also will run a 5:38 we generally also will run a 5:38 we generally also will run a antistreptolysin antibody ASO to see if 5:41 antistreptolysin antibody ASO to see if 5:41 antistreptolysin antibody ASO to see if there's any reactivity to chronic strep 5:44 there's any reactivity to chronic strep 5:44 there's any reactivity to chronic strep going on. You can test for a whole bunch 5:45 going on. You can test for a whole bunch 5:45 going on. You can test for a whole bunch of other stuff, but those are your 5:47 of other stuff, but those are your 5:47 of other stuff, but those are your basics. Now, if you had a chronic 5:48 basics. Now, if you had a chronic 5:49 basics. Now, if you had a chronic infection before like Lyme or Lyme 5:51 infection before like Lyme or Lyme 5:51 infection before like Lyme or Lyme co-infections, and now you have long 5:53 co-infections, and now you have long 5:53 co-infections, and now you have long COVID, please make sure you check back 5:55 COVID, please make sure you check back 5:55 COVID, please make sure you check back up on those that you had before. Then, 5:57 up on those that you had before. Then, 5:57 up on those that you had before. Then, the final one, which is a little harder 5:59 the final one, which is a little harder 5:59 the final one, which is a little harder to assess, are mitochondrial 6:01 to assess, are mitochondrial 6:01 to assess, are mitochondrial dysfunctions, and you can kind of assume
Mitochondrial Dysfunction and Energy Loss 6:03 dysfunctions, and you can kind of assume 6:03 dysfunctions, and you can kind of assume anybody with a fatiguing non-healing 6:05 anybody with a fatiguing non-healing 6:05 anybody with a fatiguing non-healing illness has mitochondrial dysfunction. 6:07 illness has mitochondrial dysfunction. 6:07 illness has mitochondrial dysfunction. And the bottom line with that, there are 6:09 And the bottom line with that, there are 6:09 And the bottom line with that, there are some kind of expensive, high-tech sort 6:11 some kind of expensive, high-tech sort 6:11 some kind of expensive, high-tech sort of tests you can do, which are great, 6:13 of tests you can do, which are great, 6:13 of tests you can do, which are great, and you that's fine to do, but generally 6:15 and you that's fine to do, but generally 6:16 and you that's fine to do, but generally speaking, everybody with a non-healing 6:19 speaking, everybody with a non-healing 6:19 speaking, everybody with a non-healing illness needs mitochondrial support. And 6:21 illness needs mitochondrial support. And 6:21 illness needs mitochondrial support. And I'm not going to go into what those 6:23 I'm not going to go into what those 6:23 I'm not going to go into what those things are cuz we have tons of content 6:26 things are cuz we have tons of content 6:26 things are cuz we have tons of content on supporting the mitochondria and 6:28 on supporting the mitochondria and 6:28 on supporting the mitochondria and hyperbaric and red light therapy and 6:30 hyperbaric and red light therapy and 6:30 hyperbaric and red light therapy and nutrients that support it. So, just go 6:31 nutrients that support it. So, just go 6:31 nutrients that support it. So, just go look at that other content, but that's 6:33 look at that other content, but that's 6:33 look at that other content, but that's another big area. So, the first thing, 6:35 another big area. So, the first thing, 6:35 another big area. So, the first thing, if things aren't getting better, is 6:37 if things aren't getting better, is 6:37 if things aren't getting better, is think about the undiagnosed 6:38 think about the undiagnosed 6:38 think about the undiagnosed comorbidities. And as I said, the 6:41 comorbidities. And as I said, the 6:41 comorbidities. And as I said, the biggest thing that happens is people 6:43 biggest thing that happens is people 6:43 biggest thing that happens is people that go into a clinic, and they'll say, 6:45 that go into a clinic, and they'll say, 6:45 that go into a clinic, and they'll say, "Well, you didn't have any thyroid or 6:46 "Well, you didn't have any thyroid or 6:46 "Well, you didn't have any thyroid or autoimmune problems before, so we're not
Inflammation, Clotting, and Nervous System Effects 6:48 autoimmune problems before, so we're not 6:48 autoimmune problems before, so we're not going to check that." Or we'll do just 6:49 going to check that." Or we'll do just 6:49 going to check that." Or we'll do just rudimentary testing. Well, now you do. 6:52 rudimentary testing. Well, now you do. 6:52 rudimentary testing. Well, now you do. If you don't test, you don't know. So, 6:54 If you don't test, you don't know. So, 6:54 If you don't test, you don't know. So, make sure that you get these areas 6:56 make sure that you get these areas 6:56 make sure that you get these areas tested if you're not getting better. And 6:57 tested if you're not getting better. And 6:58 tested if you're not getting better. And then, find a practitioner who's going to 7:00 then, find a practitioner who's going to 7:00 then, find a practitioner who's going to do something about the testing. One of 7:02 do something about the testing. One of 7:02 do something about the testing. One of the problems that we see with not all, 7:04 the problems that we see with not all, 7:04 the problems that we see with not all, but some specialty clinics is they may 7:06 but some specialty clinics is they may 7:06 but some specialty clinics is they may even run the tests, but they'll find 7:08 even run the tests, but they'll find 7:08 even run the tests, but they'll find positives and say, "Well, that's normal 7:10 positives and say, "Well, that's normal 7:10 positives and say, "Well, that's normal for people." It's not normal if you're 7:12 for people." It's not normal if you're 7:12 for people." It's not normal if you're sick and not getting better to have 7:14 sick and not getting better to have 7:14 sick and not getting better to have those things be positive. 7:20 The most important thing I want to take 7:20 The most important thing I want to take note of at the beginning is I want 7:23 note of at the beginning is I want 7:23 note of at the beginning is I want people to have hope because long COVID 7:26 people to have hope because long COVID 7:26 people to have hope because long COVID is a massive event in the world now, 7:29 is a massive event in the world now, 7:29 is a massive event in the world now, and there are ways to heal. There are 7:32 and there are ways to heal. There are 7:32 and there are ways to heal. There are ways to crawl out of the hole that 7:33 ways to crawl out of the hole that 7:33 ways to crawl out of the hole that you're in, and so there is hope. It just 7:36 you're in, and so there is hope. It just 7:36 you're in, and so there is hope. It just sometimes takes longer than you think it 7:38 sometimes takes longer than you think it 7:38 sometimes takes longer than you think it does because the problems are all 7:40 does because the problems are all 7:40 does because the problems are all connected, and they all talk to each 7:42 connected, and they all talk to each 7:42 connected, and they all talk to each other. So, they need some help in the 7:44 other. So, they need some help in the 7:44 other. So, they need some help in the world of chronic illness care. But, I 7:47 world of chronic illness care. But, I 7:47 world of chronic illness care. But, I want to get into a few things to 7:49 want to get into a few things to 7:49 want to get into a few things to consider in this little deeper dive 7:51 consider in this little deeper dive 7:51 consider in this little deeper dive looking at long COVID and why the 7:53 looking at long COVID and why the 7:53 looking at long COVID and why the symptoms might be either silent or 7:55 symptoms might be either silent or 7:55 symptoms might be either silent or you're disconnected from I feel this 7:58 you're disconnected from I feel this 7:58 you're disconnected from I feel this way. I don't know why that's going on in 8:00 way. I don't know why that's going on in 8:00 way. I don't know why that's going on in my body. But, I want to zero in on a few 8:03 my body. But, I want to zero in on a few 8:03 my body. But, I want to zero in on a few real big things here that I hear about 8:05 real big things here that I hear about 8:05 real big things here that I hear about daily from people. The first is a loss 8:08 daily from people. The first is a loss 8:08 daily from people. The first is a loss of energy. So, a lot of people with long 8:10 of energy. So, a lot of people with long 8:10 of energy. So, a lot of people with long COVID can have a chronic fatiguing state 8:14 COVID can have a chronic fatiguing state 8:14 COVID can have a chronic fatiguing state where maybe before they weren't the 8:16 where maybe before they weren't the 8:16 where maybe before they weren't the healthiest, but now they're just sort of 8:17 healthiest, but now they're just sort of 8:17 healthiest, but now they're just sort of really, you know, they they just never 8:19 really, you know, they they just never 8:19 really, you know, they they just never feel rested. That's really common. That 8:22 feel rested. That's really common. That 8:22 feel rested. That's really common. That comes from a number of things. But, one 8:24 comes from a number of things. But, one 8:24 comes from a number of things. But, one of the things that it comes from is a 8:26 of the things that it comes from is a 8:26 of the things that it comes from is a collusion between getting enough oxygen 8:30 collusion between getting enough oxygen 8:30 collusion between getting enough oxygen in, respiring enough carbon dioxide out, 8:33 in, respiring enough carbon dioxide out, 8:33 in, respiring enough carbon dioxide out, and operating the mitochondria on an 8:37 and operating the mitochondria on an 8:37 and operating the mitochondria on an even keel, the the right speed. If your 8:40 even keel, the the right speed. If your 8:40 even keel, the the right speed. If your mitochondria are slower, you feel more 8:44 mitochondria are slower, you feel more 8:44 mitochondria are slower, you feel more fatigued. You feel more tired. This is
Symptoms and Functional Impact of Long COVID 8:46 fatigued. You feel more tired. This is 8:46 fatigued. You feel more tired. This is very normal. So, mitochondria are one 8:48 very normal. So, mitochondria are one 8:48 very normal. So, mitochondria are one big area that have to be looked at and 8:51 big area that have to be looked at and 8:51 big area that have to be looked at and supported. And a lot of times it's more 8:53 supported. And a lot of times it's more 8:53 supported. And a lot of times it's more of a clinical trial to give you things 8:56 of a clinical trial to give you things 8:56 of a clinical trial to give you things that may be helpful to the mitochondria, 8:58 that may be helpful to the mitochondria, 8:58 that may be helpful to the mitochondria, okay? Those things could be 9:00 okay? Those things could be 9:00 okay? Those things could be mitochondrial priming substances. We use 9:03 mitochondrial priming substances. We use 9:03 mitochondrial priming substances. We use medically methylene blue. We use 9:06 medically methylene blue. We use 9:06 medically methylene blue. We use uh NAD, nicotinamide adenine 9:09 uh NAD, nicotinamide adenine 9:09 uh NAD, nicotinamide adenine dinucleotide or precursors like 9:11 dinucleotide or precursors like 9:11 dinucleotide or precursors like nicotinamide riboside or NMN. We use 9:14 nicotinamide riboside or NMN. We use 9:14 nicotinamide riboside or NMN. We use other things for the mitochondria. 9:15 other things for the mitochondria. 9:15 other things for the mitochondria. There's tons of things that help them 9:16 There's tons of things that help them 9:16 There's tons of things that help them out. But, you clinically give it a try 9:18 out. But, you clinically give it a try 9:18 out. But, you clinically give it a try and see if the body starts to work. 9:20 and see if the body starts to work. 9:20 and see if the body starts to work. Well, what else can affect your energy 9:21 Well, what else can affect your energy 9:21 Well, what else can affect your energy through the mitochondria? What if your 9:23 through the mitochondria? What if your 9:23 through the mitochondria? What if your hormone system gets messed up? So, your 9:25 hormone system gets messed up? So, your 9:25 hormone system gets messed up? So, your thyroid can be very important because 9:27 thyroid can be very important because 9:27 thyroid can be very important because you can get new problems you never had 9:29 you can get new problems you never had 9:29 you can get new problems you never had in your whole life before, and you need 9:31 in your whole life before, and you need 9:31 in your whole life before, and you need to look at these other inhibitory areas 9:33 to look at these other inhibitory areas 9:33 to look at these other inhibitory areas like thyroid antibodies, reverse T3, and 9:36 like thyroid antibodies, reverse T3, and 9:36 like thyroid antibodies, reverse T3, and then T3, T4, TSH, etc. And that's 9:39 then T3, T4, TSH, etc. And that's 9:39 then T3, T4, TSH, etc. And that's because your thyroid runs your metabolic 9:41 because your thyroid runs your metabolic 9:41 because your thyroid runs your metabolic rate, which is the speed of your 9:42 rate, which is the speed of your 9:42 rate, which is the speed of your mitochondria. So, very important there. 9:44 mitochondria. So, very important there. 9:45 mitochondria. So, very important there. The next is your adrenal hormone output, 9:48 The next is your adrenal hormone output, 9:48 The next is your adrenal hormone output, and that is cortisol primarily that we 9:50 and that is cortisol primarily that we 9:50 and that is cortisol primarily that we look at as screening. Different cortisol 9:52 look at as screening. Different cortisol 9:52 look at as screening. Different cortisol tests can be done, but a lot of people 9:54 tests can be done, but a lot of people 9:55 tests can be done, but a lot of people with uh long COVID will either have very 9:57 with uh long COVID will either have very 9:57 with uh long COVID will either have very low or maybe elevated cortisol, and that 9:59 low or maybe elevated cortisol, and that 9:59 low or maybe elevated cortisol, and that needs to be sorted out with blood tests. 10:01 needs to be sorted out with blood tests. 10:01 needs to be sorted out with blood tests. The next thing is which is not commonly 10:04 The next thing is which is not commonly 10:04 The next thing is which is not commonly looked at, but should be, are your 10:06 looked at, but should be, are your 10:06 looked at, but should be, are your primary reproductive hormones. 10:08 primary reproductive hormones. 10:08 primary reproductive hormones. Testosterone, men or women, estrogens, 10:11 Testosterone, men or women, estrogens, 10:11 Testosterone, men or women, estrogens, men or women, they're just tested a 10:12 men or women, they're just tested a 10:12 men or women, they're just tested a little differently. And then 10:13 little differently. And then 10:13 little differently. And then progesterone, men or women. Usually 10:15 progesterone, men or women. Usually 10:15 progesterone, men or women. Usually androgens like testosterone, you also 10:17 androgens like testosterone, you also 10:17 androgens like testosterone, you also check DHEA. Why do I say that men or 10:20 check DHEA. Why do I say that men or 10:20 check DHEA. Why do I say that men or women? Because we both, males and 10:21 women? Because we both, males and 10:21 women? Because we both, males and females, use all of those hormones, we 10:23 females, use all of those hormones, we 10:23 females, use all of those hormones, we just use them in different ratios and 10:25 just use them in different ratios and 10:25 just use them in different ratios and stuff. If your androgens, your 10:27 stuff. If your androgens, your 10:27 stuff. If your androgens, your testosterone or DHEA or something have 10:29 testosterone or DHEA or something have 10:29 testosterone or DHEA or something have crashed, male or female, you will not 10:31 crashed, male or female, you will not 10:31 crashed, male or female, you will not heal normal. We've known this in chronic 10:33 heal normal. We've known this in chronic 10:33 heal normal. We've known this in chronic illness medicine for a long time. It's 10:35 illness medicine for a long time. It's 10:35 illness medicine for a long time. It's very common for androgens to crash when 10:37 very common for androgens to crash when 10:37 very common for androgens to crash when you've been very sick. If your estrogen 10:39 you've been very sick. If your estrogen 10:39 you've been very sick. If your estrogen progesterone, male or female, it's out
Movement, Diet, and Hydration Support 10:41 progesterone, male or female, it's out 10:42 progesterone, male or female, it's out of balance, testosterone's down, 10:43 of balance, testosterone's down, 10:44 of balance, testosterone's down, estrogen's high, you become more 10:45 estrogen's high, you become more 10:45 estrogen's high, you become more inflamed, men or women, it doesn't 10:47 inflamed, men or women, it doesn't 10:47 inflamed, men or women, it doesn't matter, and the neurological 10:48 matter, and the neurological 10:48 matter, and the neurological inflammation will go on, etc. So, you 10:50 inflammation will go on, etc. So, you 10:50 inflammation will go on, etc. So, you want to have not just your thyroid and 10:52 want to have not just your thyroid and 10:52 want to have not just your thyroid and adrenals looked at, you also want to 10:54 adrenals looked at, you also want to 10:54 adrenals looked at, you also want to take a look at uh your reproductive 10:56 take a look at uh your reproductive 10:56 take a look at uh your reproductive hormones as well. They all need help 10:58 hormones as well. They all need help 10:58 hormones as well. They all need help probably, especially the longer that 11:00 probably, especially the longer that 11:00 probably, especially the longer that you've been sick. The other way you can 11:02 you've been sick. The other way you can 11:02 you've been sick. The other way you can look at these things I'm talking to you 11:03 look at these things I'm talking to you 11:03 look at these things I'm talking to you about is these might be areas to turn 11:05 about is these might be areas to turn 11:05 about is these might be areas to turn over rocks and look under if you've 11:06 over rocks and look under if you've 11:06 over rocks and look under if you've gotten some help with your long COVID, 11:08 gotten some help with your long COVID, 11:08 gotten some help with your long COVID, but you're not getting where you feel 11:10 but you're not getting where you feel 11:10 but you're not getting where you feel like you need to go. Other things that 11:12 like you need to go. Other things that 11:12 like you need to go. Other things that that can affect your energy uh beyond 11:14 that can affect your energy uh beyond 11:14 that can affect your energy uh beyond just your mitochondria slowing down 11:16 just your mitochondria slowing down 11:16 just your mitochondria slowing down would be an increase in sensitivity, 11:19 would be an increase in sensitivity, 11:19 would be an increase in sensitivity, maybe exposure, but sensitivity to 11:21 maybe exposure, but sensitivity to 11:21 maybe exposure, but sensitivity to toxicants in your body, toxins. See, a 11:23 toxicants in your body, toxins. See, a 11:23 toxicants in your body, toxins. See, a lot of people didn't have any trouble 11:24 lot of people didn't have any trouble 11:24 lot of people didn't have any trouble before COVID, and now they're uh more 11:27 before COVID, and now they're uh more 11:27 before COVID, and now they're uh more sensitive to mold mycotoxins or 11:30 sensitive to mold mycotoxins or 11:30 sensitive to mold mycotoxins or chemicals in their environment or 11:31 chemicals in their environment or 11:32 chemicals in their environment or metals. So, they'll have a mast cell 11:34 metals. So, they'll have a mast cell 11:34 metals. So, they'll have a mast cell activation that starts after or with 11:37 activation that starts after or with 11:37 activation that starts after or with long COVID, multiple chemical 11:38 long COVID, multiple chemical 11:38 long COVID, multiple chemical sensitivity, all that stuff. That's 11:40 sensitivity, all that stuff. That's 11:40 sensitivity, all that stuff. That's another big thing. People say, "Well, 11:41 another big thing. People say, "Well, 11:41 another big thing. People say, "Well, why is this going on at same time?" It's 11:43 why is this going on at same time?" It's 11:43 why is this going on at same time?" It's because those things are sensitivity 11:46 because those things are sensitivity 11:46 because those things are sensitivity levels that your body either gets 11:48 levels that your body either gets 11:48 levels that your body either gets symptoms to or doesn't. So, mast cell 11:50 symptoms to or doesn't. So, mast cell 11:50 symptoms to or doesn't. So, mast cell activation can either not be present 11:52 activation can either not be present 11:52 activation can either not be present before COVID and then present after or 11:55 before COVID and then present after or 11:55 before COVID and then present after or present at a low level you don't notice 11:56 present at a low level you don't notice 11:56 present at a low level you don't notice and suddenly your body's just reacting 11:58 and suddenly your body's just reacting 11:58 and suddenly your body's just reacting to everything. It's another reason it 12:00 to everything. It's another reason it 12:00 to everything. It's another reason it can really drag you down and make your 12:02 can really drag you down and make your 12:02 can really drag you down and make your case much more complex because now you 12:04 case much more complex because now you 12:04 case much more complex because now you have chemical sensitivities, mast cell 12:07 have chemical sensitivities, mast cell 12:07 have chemical sensitivities, mast cell activation, all of those things that you 12:08 activation, all of those things that you 12:08 activation, all of those things that you don't want, right? Another thing that 12:10 don't want, right? Another thing that 12:10 don't want, right? Another thing that normally is looked at if you're getting 12:12 normally is looked at if you're getting 12:12 normally is looked at if you're getting checked out for long COVID, or really 12:14 checked out for long COVID, or really 12:14 checked out for long COVID, or really you should make sure it was, are the 12:15 you should make sure it was, are the 12:15 you should make sure it was, are the inflammatory markers in your vascular 12:18 inflammatory markers in your vascular 12:18 inflammatory markers in your vascular system and just globally in your body. 12:20 system and just globally in your body. 12:20 system and just globally in your body. So, some of these that we see that will 12:22 So, some of these that we see that will 12:22 So, some of these that we see that will trend up would be sedimentation rate 12:25 trend up would be sedimentation rate 12:25 trend up would be sedimentation rate and/or the C-reactive protein, the CRP, 12:28 and/or the C-reactive protein, the CRP, 12:28 and/or the C-reactive protein, the CRP, LDH, 12:29 LDH, 12:30 LDH, state dehydrogenase, common thing on 12:32 state dehydrogenase, common thing on 12:32 state dehydrogenase, common thing on chemistry panels to look at. Sometimes 12:34 chemistry panels to look at. Sometimes 12:34 chemistry panels to look at. Sometimes alkaline phosphatase will go up. And 12:36 alkaline phosphatase will go up. And 12:36 alkaline phosphatase will go up. And then also other things that previously 12:37 then also other things that previously 12:38 then also other things that previously we only associated with, you know, 12:40 we only associated with, you know, 12:40 we only associated with, you know, clotting and other inflammation, be like 12:42 clotting and other inflammation, be like 12:42 clotting and other inflammation, be like fibrinogen and then the D-dimer, those 12:45 fibrinogen and then the D-dimer, those 12:45 fibrinogen and then the D-dimer, those can go up in people. They should just be 12:46 can go up in people. They should just be 12:46 can go up in people. They should just be ruled out, check, make sure. And then 12:48 ruled out, check, make sure. And then 12:48 ruled out, check, make sure. And then there's other in global inflammatory 12:51 there's other in global inflammatory 12:51 there's other in global inflammatory markers like ferritin can go up, etc. We 12:53 markers like ferritin can go up, etc. We 12:53 markers like ferritin can go up, etc. We normally look at all of these with 12:54 normally look at all of these with 12:54 normally look at all of these with somebody just as a baseline to make sure 12:56 somebody just as a baseline to make sure 12:56 somebody just as a baseline to make sure we're not missing that, "Oh gee, you 12:58 we're not missing that, "Oh gee, you 12:58 we're not missing that, "Oh gee, you know, their fibrinogen is elevated, 13:00 know, their fibrinogen is elevated, 13:00 know, their fibrinogen is elevated, their D-dimer is elevated. We need to 13:02 their D-dimer is elevated. We need to 13:02 their D-dimer is elevated. We need to watch, make sure they're not having 13:04 watch, make sure they're not having 13:04 watch, make sure they're not having microclots or macroclots. Need to do 13:06 microclots or macroclots. Need to do 13:06 microclots or macroclots. Need to do something about that till we get the 13:07 something about that till we get the 13:07 something about that till we get the inflammation down." And then those 13:09 inflammation down." And then those 13:09 inflammation down." And then those things go back to normal. So, a lot of 13:11 things go back to normal. So, a lot of 13:11 things go back to normal. So, a lot of those things are surrogate markers that 13:13 those things are surrogate markers that 13:13 those things are surrogate markers that we're winning with long COVID when those 13:15 we're winning with long COVID when those 13:15 we're winning with long COVID when those other inflammatory labs go down. And you 13:17 other inflammatory labs go down. And you 13:17 other inflammatory labs go down. And you might say, "Well, how could that affect 13:19 might say, "Well, how could that affect 13:19 might say, "Well, how could that affect me in the way I feel?" Well, there's a 13:21 me in the way I feel?" Well, there's a 13:21 me in the way I feel?" Well, there's a number of ways they can affect you in 13:24 number of ways they can affect you in 13:24 number of ways they can affect you in the way that they feel, but the most 13:25 the way that they feel, but the most 13:25 the way that they feel, but the most dangerous thing that we are concerned 13:28 dangerous thing that we are concerned 13:28 dangerous thing that we are concerned about is the clotting spectrum. 13:30 about is the clotting spectrum. 13:30 about is the clotting spectrum. Obviously, if you get a big clot like a 13:31 Obviously, if you get a big clot like a 13:31 Obviously, if you get a big clot like a pulmonary embolism or some other thing, 13:34 pulmonary embolism or some other thing, 13:34 pulmonary embolism or some other thing, you'll be in the hospital, you know that 13:35 you'll be in the hospital, you know that 13:35 you'll be in the hospital, you know that right away. But, there's a lot of papers 13:37 right away. But, there's a lot of papers 13:37 right away. But, there's a lot of papers coming out now on micro clotting. And 13:39 coming out now on micro clotting. And 13:39 coming out now on micro clotting. And so, micro clotting can go on and it 13:42 so, micro clotting can go on and it 13:42 so, micro clotting can go on and it might slowly affect areas where there's 13:44 might slowly affect areas where there's 13:44 might slowly affect areas where there's very sensitive vasculature. Your eyes 13:47 very sensitive vasculature. Your eyes 13:47 very sensitive vasculature. Your eyes are one area, your kidneys are another 13:49 are one area, your kidneys are another 13:49 are one area, your kidneys are another area, terminal blood vessels, fingers, 13:52 area, terminal blood vessels, fingers, 13:52 area, terminal blood vessels, fingers, toes, you know, feet and hands, stuff 13:54 toes, you know, feet and hands, stuff 13:54 toes, you know, feet and hands, stuff like that. Lots of areas, maybe even the 13:56 like that. Lots of areas, maybe even the 13:56 like that. Lots of areas, maybe even the brain. So, this is why I always check 13:59 brain. So, this is why I always check 13:59 brain. So, this is why I always check all of these inflammatory markers 14:01 all of these inflammatory markers 14:01 all of these inflammatory markers including the cardiovascular ones 14:02 including the cardiovascular ones 14:02 including the cardiovascular ones because if somebody has elevated general 14:05 because if somebody has elevated general 14:05 because if somebody has elevated general inflammatory markers, but the 14:07 inflammatory markers, but the 14:07 inflammatory markers, but the cardiovascular ones are elevated, we 14:09 cardiovascular ones are elevated, we 14:09 cardiovascular ones are elevated, we need to give them things to make sure 14:10 need to give them things to make sure 14:10 need to give them things to make sure that they're not going to clot or they 14:12 that they're not going to clot or they 14:12 that they're not going to clot or they have the least chance of clotting until 14:14 have the least chance of clotting until 14:14 have the least chance of clotting until we work on the bigger issue of the long 14:18 we work on the bigger issue of the long 14:18 we work on the bigger issue of the long COVID syndrome, get the inflammation to 14:20 COVID syndrome, get the inflammation to 14:20 COVID syndrome, get the inflammation to go down. And so, the nervous system 14:22 go down. And so, the nervous system 14:22 go down. And so, the nervous system obviously controls everything. The 14:24 obviously controls everything. The 14:24 obviously controls everything. The nervous system, we need to understand 14:26 nervous system, we need to understand 14:26 nervous system, we need to understand and this is in the neurology literature. 14:29 and this is in the neurology literature. 14:29 and this is in the neurology literature. This is not just some idea out there. 14:31 This is not just some idea out there. 14:31 This is not just some idea out there. COVID can affect the nervous system the 14:34 COVID can affect the nervous system the 14:34 COVID can affect the nervous system the same way a head trauma does. And so, 14:37 same way a head trauma does. And so, 14:37 same way a head trauma does. And so, neurologists writing about this will 14:39 neurologists writing about this will 14:39 neurologists writing about this will say, "COVID and long COVID can be the 14:42 say, "COVID and long COVID can be the 14:42 say, "COVID and long COVID can be the same neurological pathology as a 14:45 same neurological pathology as a 14:45 same neurological pathology as a traumatic brain injury. But, people 14:47 traumatic brain injury. But, people 14:47 traumatic brain injury. But, people don't realize it because they didn't hit 14:50 don't realize it because they didn't hit 14:50 don't realize it because they didn't hit their head. They had COVID." That is not 14:53 their head. They had COVID." That is not 14:53 their head. They had COVID." That is not good because traumatic brain injuries 14:55 good because traumatic brain injuries 14:55 good because traumatic brain injuries affect everything in your body. They 14:57 affect everything in your body. They 14:57 affect everything in your body. They create chronic illness, they create all 14:58 create chronic illness, they create all 14:58 create chronic illness, they create all sorts of stuff and they're very slow to 15:01 sorts of stuff and they're very slow to 15:01 sorts of stuff and they're very slow to treat often. So, if you're getting 15:02 treat often. So, if you're getting 15:02 treat often. So, if you're getting frustrated, we we all understand that, 15:04 frustrated, we we all understand that, 15:04 frustrated, we we all understand that, but the traumatic brain injury part of 15:07 but the traumatic brain injury part of 15:07 but the traumatic brain injury part of COVID as an event is something that 15:10 COVID as an event is something that 15:10 COVID as an event is something that often gets overlooked. We we don't think 15:12 often gets overlooked. We we don't think 15:12 often gets overlooked. We we don't think about how inflammatory that is and how 15:14 about how inflammatory that is and how 15:14 about how inflammatory that is and how deregulating. So, that then can lead you 15:16 deregulating. So, that then can lead you 15:16 deregulating. So, that then can lead you to changes in sensitivity of pain. You 15:19 to changes in sensitivity of pain. You 15:19 to changes in sensitivity of pain. You can get more pain. It can throw your 15:21 can get more pain. It can throw your 15:21 can get more pain. It can throw your sleep off. It can make you more anxious 15:23 sleep off. It can make you more anxious 15:23 sleep off. It can make you more anxious or depressed or if you have a little uh 15:26 or depressed or if you have a little uh 15:26 or depressed or if you have a little uh you know OCD or inattentive issues, it 15:28 you know OCD or inattentive issues, it 15:28 you know OCD or inattentive issues, it makes it worse sometimes. Anything your 15:30 makes it worse sometimes. Anything your 15:30 makes it worse sometimes. Anything your brain does, it may it worse. But, your 15:32 brain does, it may it worse. But, your 15:32 brain does, it may it worse. But, your brain also helps you control other stuff 15:34 brain also helps you control other stuff 15:34 brain also helps you control other stuff we talked about like your metabolic rate 15:36 we talked about like your metabolic rate 15:36 we talked about like your metabolic rate and your hormone. So, if the feedback is 15:38 and your hormone. So, if the feedback is 15:38 and your hormone. So, if the feedback is messed up between your peripheral system 15:40 messed up between your peripheral system 15:40 messed up between your peripheral system helping your metabolic rate, whether 15:41 helping your metabolic rate, whether 15:42 helping your metabolic rate, whether it's through hormones or uh other 15:43 it's through hormones or uh other 15:43 it's through hormones or uh other nutrient manipulation, etc., and your 15:46 nutrient manipulation, etc., and your 15:46 nutrient manipulation, etc., and your brain is involved in that, you could see 15:48 brain is involved in that, you could see 15:48 brain is involved in that, you could see that harming your brain is going to have 15:49 that harming your brain is going to have 15:49 that harming your brain is going to have a big downstream effect. And in my 15:51 a big downstream effect. And in my 15:51 a big downstream effect. And in my experience, getting the neurological 15:53 experience, getting the neurological 15:53 experience, getting the neurological inflammation healed up and and back on 15:55 inflammation healed up and and back on 15:55 inflammation healed up and and back on track is one of the core things you have 15:57 track is one of the core things you have 15:57 track is one of the core things you have to do, but it's very slow for for some 16:00 to do, but it's very slow for for some 16:00 to do, but it's very slow for for some people with long COVID as well. I want 16:02 people with long COVID as well. I want 16:02 people with long COVID as well. I want to remind you that although it may take 16:04 to remind you that although it may take 16:04 to remind you that although it may take some searching, it may take some looking 16:06 some searching, it may take some looking 16:06 some searching, it may take some looking around, if you're not getting the help 16:08 around, if you're not getting the help 16:08 around, if you're not getting the help you need with long COVID, find people 16:11 you need with long COVID, find people 16:11 you need with long COVID, find people who are chronic illness-oriented in the 16:13 who are chronic illness-oriented in the 16:13 who are chronic illness-oriented in the health-care space. They'll understand 16:15 health-care space. They'll understand 16:15 health-care space. They'll understand the language of chronic illness better 16:17 the language of chronic illness better 16:17 the language of chronic illness better and they'll understand the language of 16:19 and they'll understand the language of 16:19 and they'll understand the language of what creates long COVID better, and you 16:21 what creates long COVID better, and you 16:21 what creates long COVID better, and you can be helped. As far as top symptomatic 16:25 can be helped. As far as top symptomatic 16:25 can be helped. As far as top symptomatic areas or top presentations, there's four 16:28 areas or top presentations, there's four 16:28 areas or top presentations, there's four big ones, and then they can break down 16:30 big ones, and then they can break down 16:30 big ones, and then they can break down into a bunch of other ones. First one is 16:33 into a bunch of other ones. First one is 16:33 into a bunch of other ones. First one is fatigue. A lot of people will liken long 16:35 fatigue. A lot of people will liken long 16:35 fatigue. A lot of people will liken long COVID to you know chronic fatigue 16:38 COVID to you know chronic fatigue 16:38 COVID to you know chronic fatigue syndrome, CFS, has a lot of the same 16:41 syndrome, CFS, has a lot of the same 16:41 syndrome, CFS, has a lot of the same features. The next one, which is very 16:43 features. The next one, which is very 16:43 features. The next one, which is very disturbing, is what we call brain fog. 16:46 disturbing, is what we call brain fog. 16:46 disturbing, is what we call brain fog. Now, a lot of people have experienced 16:47 Now, a lot of people have experienced 16:47 Now, a lot of people have experienced brain fog from certain drug therapies. 16:50 brain fog from certain drug therapies. 16:50 brain fog from certain drug therapies. They might get it from chemotherapy or 16:51 They might get it from chemotherapy or 16:52 They might get it from chemotherapy or certain other things. But, if you 16:53 certain other things. But, if you 16:53 certain other things. But, if you weren't having slow mentation, brain fog 16:55 weren't having slow mentation, brain fog 16:55 weren't having slow mentation, brain fog before and now you have long COVID and 16:58 before and now you have long COVID and 16:58 before and now you have long COVID and you feel like you have brain fog, it's 17:00 you feel like you have brain fog, it's 17:00 you feel like you have brain fog, it's very, very frustrating because it's a 17:02 very, very frustrating because it's a 17:02 very, very frustrating because it's a lot like the feeling as if you got a 17:03 lot like the feeling as if you got a 17:04 lot like the feeling as if you got a concussion or something. Your brain is 17:05 concussion or something. Your brain is 17:05 concussion or something. Your brain is not working like it it ought to. The 17:07 not working like it it ought to. The 17:07 not working like it it ought to. The next are pain syndromes, and this can be 17:09 next are pain syndromes, and this can be 17:09 next are pain syndromes, and this can be either peripheral pain where my muscles 17:12 either peripheral pain where my muscles 17:12 either peripheral pain where my muscles hurt or my digestive system is achy, or 17:14 hurt or my digestive system is achy, or 17:14 hurt or my digestive system is achy, or it can be central pain where my pain 17:17 it can be central pain where my pain 17:17 it can be central pain where my pain apparatus in the brain is just thrown 17:19 apparatus in the brain is just thrown 17:19 apparatus in the brain is just thrown off because of inflammation, my pain 17:21 off because of inflammation, my pain 17:21 off because of inflammation, my pain threshold has changed. So, I hurt more 17:23 threshold has changed. So, I hurt more 17:23 threshold has changed. So, I hurt more than I used to. And then the last one, 17:25 than I used to. And then the last one, 17:25 than I used to. And then the last one, which is a large area, would be other 17:28 which is a large area, would be other 17:28 which is a large area, would be other neurological symptoms. Now, this could 17:30 neurological symptoms. Now, this could 17:30 neurological symptoms. Now, this could break down into direct neurological 17:33 break down into direct neurological 17:33 break down into direct neurological problems, meaning things such as 17:35 problems, meaning things such as 17:35 problems, meaning things such as peripheral neuropathy or changes in 17:38 peripheral neuropathy or changes in 17:38 peripheral neuropathy or changes in taste and smell or other things like 17:40 taste and smell or other things like 17:40 taste and smell or other things like that, or it could break down into more 17:43 that, or it could break down into more 17:43 that, or it could break down into more of a neuro neuroemotional type of the 17:45 of a neuro neuroemotional type of the 17:45 of a neuro neuroemotional type of the change where now you're not sleeping 17:47 change where now you're not sleeping 17:47 change where now you're not sleeping well or now you're more anxious or now 17:49 well or now you're more anxious or now 17:49 well or now you're more anxious or now you're more depressed or any number of 17:51 you're more depressed or any number of 17:52 you're more depressed or any number of other things, so neurological things. 17:54 other things, so neurological things. 17:54 other things, so neurological things. And so, what I want to look at here in 17:55 And so, what I want to look at here in 17:55 And so, what I want to look at here in the first video is when somebody comes 17:58 the first video is when somebody comes 17:58 the first video is when somebody comes either, you know, I am directly working 18:01 either, you know, I am directly working 18:01 either, you know, I am directly working with them or I'm consulting clinic or 18:03 with them or I'm consulting clinic or 18:03 with them or I'm consulting clinic or teaching them, you know, what what's the 18:05 teaching them, you know, what what's the 18:06 teaching them, you know, what what's the pathway to go through here. The first 18:08 pathway to go through here. The first 18:08 pathway to go through here. The first thing that we do, and it's stepwise, the 18:10 thing that we do, and it's stepwise, the 18:10 thing that we do, and it's stepwise, the first thing is to rule out pathologies. 18:13 first thing is to rule out pathologies. 18:13 first thing is to rule out pathologies. So, for whatever reason, it might not 18:15 So, for whatever reason, it might not 18:15 So, for whatever reason, it might not even had anything to do with COVID, but 18:17 even had anything to do with COVID, but 18:17 even had anything to do with COVID, but people are allowed to have more than one 18:20 people are allowed to have more than one 18:20 people are allowed to have more than one reason for medical problems. What we 18:22 reason for medical problems. What we 18:22 reason for medical problems. What we know is people with long COVID can have 18:25 know is people with long COVID can have 18:25 know is people with long COVID can have pathological dysfunction. So, the first 18:28 pathological dysfunction. So, the first 18:28 pathological dysfunction. So, the first thing is to rule out pathologies, 18:30 thing is to rule out pathologies, 18:30 thing is to rule out pathologies, meaning let's make sure your kidneys are 18:32 meaning let's make sure your kidneys are 18:32 meaning let's make sure your kidneys are functioning. Let's make sure your liver 18:34 functioning. Let's make sure your liver 18:34 functioning. Let's make sure your liver is functioning. Let's make sure you 18:35 is functioning. Let's make sure you 18:35 is functioning. Let's make sure you haven't developed some new autoimmune 18:38 haven't developed some new autoimmune 18:38 haven't developed some new autoimmune disease. Let's make sure your 18:40 disease. Let's make sure your 18:40 disease. Let's make sure your cardiovascular system and your pulmonary 18:42 cardiovascular system and your pulmonary 18:42 cardiovascular system and your pulmonary system are not suffering in some way 18:45 system are not suffering in some way 18:45 system are not suffering in some way pathologically, because we don't want to 18:47 pathologically, because we don't want to 18:47 pathologically, because we don't want to launch into treating a whole bunch of 18:48 launch into treating a whole bunch of 18:49 launch into treating a whole bunch of other things which may still need to be 18:51 other things which may still need to be 18:51 other things which may still need to be treated and overlook the fact that you 18:54 treated and overlook the fact that you 18:54 treated and overlook the fact that you have suffered lower kidney function or 18:56 have suffered lower kidney function or 18:57 have suffered lower kidney function or overlook the fact that you have a 18:59 overlook the fact that you have a 18:59 overlook the fact that you have a neuropsychiatric disorder that's pretty 19:01 neuropsychiatric disorder that's pretty 19:01 neuropsychiatric disorder that's pretty hardcore that we need to get under 19:02 hardcore that we need to get under 19:02 hardcore that we need to get under control or overlook the fact that you 19:05 control or overlook the fact that you 19:05 control or overlook the fact that you have some restrictive disease in your 19:07 have some restrictive disease in your 19:07 have some restrictive disease in your lung or something like that. But a lot 19:08 lung or something like that. But a lot 19:08 lung or something like that. But a lot of people come to other providers 19:10 of people come to other providers 19:10 of people come to other providers because they are frustrated and they 19:12 because they are frustrated and they 19:12 because they are frustrated and they say, well, thank heaven I don't have any 19:14 say, well, thank heaven I don't have any 19:14 say, well, thank heaven I don't have any hardcore pathology. My kidneys, liver, 19:17 hardcore pathology. My kidneys, liver, 19:17 hardcore pathology. My kidneys, liver, heart, lungs, brain, they're all 19:19 heart, lungs, brain, they're all 19:19 heart, lungs, brain, they're all supposedly working great based on the 19:21 supposedly working great based on the 19:21 supposedly working great based on the test, but I still feel horrible. So, 19:22 test, but I still feel horrible. So, 19:22 test, but I still feel horrible. So, then what do we do? Well, obviously, if 19:24 then what do we do? Well, obviously, if 19:24 then what do we do? Well, obviously, if there's a pathology, we're going to 19:26 there's a pathology, we're going to 19:26 there's a pathology, we're going to start treating that and that if there's 19:27 start treating that and that if there's 19:27 start treating that and that if there's functional or other things in the labs, 19:30 functional or other things in the labs, 19:30 functional or other things in the labs, we're going to start treating that. But 19:31 we're going to start treating that. But 19:31 we're going to start treating that. But then there's things that we can do for 19:33 then there's things that we can do for 19:33 then there's things that we can do for ourselves that you might get really 19:34 ourselves that you might get really 19:35 ourselves that you might get really frustrated and say, well, this didn't 19:36 frustrated and say, well, this didn't 19:36 frustrated and say, well, this didn't help me or it doesn't seem very strong 19:38 help me or it doesn't seem very strong 19:38 help me or it doesn't seem very strong or whatever, but it's going to help 19:40 or whatever, but it's going to help 19:40 or whatever, but it's going to help anyway. So, these are things that we can 19:42 anyway. So, these are things that we can 19:42 anyway. So, these are things that we can work on, either you work on on your own 19:44 work on, either you work on on your own 19:44 work on, either you work on on your own or we work on together to help out. The 19:46 or we work on together to help out. The 19:46 or we work on together to help out. The first thing is trying to restore normal 19:49 first thing is trying to restore normal 19:49 first thing is trying to restore normal sleep function. And nowadays, this used 19:52 sleep function. And nowadays, this used 19:52 sleep function. And nowadays, this used to be really hard to track with people 19:55 to be really hard to track with people 19:55 to be really hard to track with people because the sleep monitors were these 19:56 because the sleep monitors were these 19:56 because the sleep monitors were these giant things people would have at home 19:58 giant things people would have at home 19:58 giant things people would have at home and they wouldn't use them. Now, you can 20:00 and they wouldn't use them. Now, you can 20:00 and they wouldn't use them. Now, you can use an Aura ring or you can use a watt. 20:02 use an Aura ring or you can use a watt. 20:02 use an Aura ring or you can use a watt. Are they perfect? No, they're not, but 20:04 Are they perfect? No, they're not, but 20:04 Are they perfect? No, they're not, but you can get a general idea of how long 20:07 you can get a general idea of how long 20:07 you can get a general idea of how long am I actually sleeping. You might be 20:08 am I actually sleeping. You might be 20:08 am I actually sleeping. You might be unconscious for at x amount of time, but 20:11 unconscious for at x amount of time, but 20:11 unconscious for at x amount of time, but you may not be going into good, you 20:12 you may not be going into good, you 20:12 you may not be going into good, you know, deeper sleep and all that. So, 20:14 know, deeper sleep and all that. So, 20:14 know, deeper sleep and all that. So, that's really good to look for and look 20:15 that's really good to look for and look 20:15 that's really good to look for and look at. Now, you might say if if you're 20:17 at. Now, you might say if if you're 20:17 at. Now, you might say if if you're fatigued, well, I'm sleeping all the 20:18 fatigued, well, I'm sleeping all the 20:18 fatigued, well, I'm sleeping all the time. Well, then sleep normalization is 20:20 time. Well, then sleep normalization is 20:20 time. Well, then sleep normalization is getting you some energy back. The next 20:22 getting you some energy back. The next 20:22 getting you some energy back. The next thing is movement. Now, people will say, 20:24 thing is movement. Now, people will say, 20:24 thing is movement. Now, people will say, well, does this really make a lot of 20:26 well, does this really make a lot of 20:26 well, does this really make a lot of difference? Actually, it does and you 20:28 difference? Actually, it does and you 20:28 difference? Actually, it does and you don't have to do a ton. The first thing 20:30 don't have to do a ton. The first thing 20:30 don't have to do a ton. The first thing about movement is the most important 20:32 about movement is the most important 20:32 about movement is the most important thing for you to move are your skeletal 20:34 thing for you to move are your skeletal 20:34 thing for you to move are your skeletal muscles that move your body. So, your 20:37 muscles that move your body. So, your 20:37 muscles that move your body. So, your legs are huge and then the core muscles 20:40 legs are huge and then the core muscles 20:40 legs are huge and then the core muscles that move you around. The next thing 20:41 that move you around. The next thing 20:41 that move you around. The next thing about movement is you don't have to do a 20:44 about movement is you don't have to do a 20:44 about movement is you don't have to do a ton to make an impact. It's getting the 20:47 ton to make an impact. It's getting the 20:47 ton to make an impact. It's getting the muscles moving. The next thing is you 20:49 muscles moving. The next thing is you 20:49 muscles moving. The next thing is you start where you're at. So, let's say 20:52 start where you're at. So, let's say 20:52 start where you're at. So, let's say you're on one end of the spectrum and 20:53 you're on one end of the spectrum and 20:53 you're on one end of the spectrum and you were super athletic and you were 20:56 you were super athletic and you were 20:56 you were super athletic and you were doing weightlifting and aerobic training 20:59 doing weightlifting and aerobic training 20:59 doing weightlifting and aerobic training all week long and you were really there 21:01 all week long and you were really there 21:01 all week long and you were really there and now you got long COVID and you're 21:03 and now you got long COVID and you're 21:03 and now you got long COVID and you're fatigued and you're you're at 25% of 21:06 fatigued and you're you're at 25% of 21:06 fatigued and you're you're at 25% of your previous capacity, you know, at the 21:08 your previous capacity, you know, at the 21:08 your previous capacity, you know, at the gym. Well, we start at 25%. So, you 21:11 gym. Well, we start at 25%. So, you 21:11 gym. Well, we start at 25%. So, you don't have to go back to 100%. You don't 21:12 don't have to go back to 100%. You don't 21:12 don't have to go back to 100%. You don't fatigue yourself more. You do baby 21:14 fatigue yourself more. You do baby 21:14 fatigue yourself more. You do baby steps. And in the beginning, the baby 21:16 steps. And in the beginning, the baby 21:16 steps. And in the beginning, the baby steps are very long. So, it's just a 21:18 steps are very long. So, it's just a 21:18 steps are very long. So, it's just a little bit more every day. What about 21:19 little bit more every day. What about 21:19 little bit more every day. What about the other end of the spectrum? Let's say 21:21 the other end of the spectrum? Let's say 21:21 the other end of the spectrum? Let's say you've not worked out ever and basically 21:24 you've not worked out ever and basically 21:24 you've not worked out ever and basically need to work out. You feel like you need 21:25 need to work out. You feel like you need 21:25 need to work out. You feel like you need to work out, but you feel horrible cuz 21:27 to work out, but you feel horrible cuz 21:27 to work out, but you feel horrible cuz long COVID and you're way out of 21:28 long COVID and you're way out of 21:28 long COVID and you're way out of condition. You're deconditioned, etc. 21:30 condition. You're deconditioned, etc. 21:30 condition. You're deconditioned, etc. Well, then we're starting with that. 21:32 Well, then we're starting with that. 21:32 Well, then we're starting with that. You're deconditioned. We're going to 21:33 You're deconditioned. We're going to 21:33 You're deconditioned. We're going to just do enough to get your muscles 21:35 just do enough to get your muscles 21:35 just do enough to get your muscles moving for maybe a month or two. That 21:37 moving for maybe a month or two. That 21:37 moving for maybe a month or two. That might be what's your normal activity 21:39 might be what's your normal activity 21:39 might be what's your normal activity during a day. A person might say, "Well, 21:41 during a day. A person might say, "Well, 21:41 during a day. A person might say, "Well, I go up and down the stairs four or five 21:42 I go up and down the stairs four or five 21:42 I go up and down the stairs four or five times. I walk to the mailbox. I do all 21:44 times. I walk to the mailbox. I do all 21:45 times. I walk to the mailbox. I do all these things." And that that's about all 21:46 these things." And that that's about all 21:46 these things." And that that's about all I can handle. We might just add one 21:49 I can handle. We might just add one 21:49 I can handle. We might just add one thing. Make another loop to the mailbox. 21:51 thing. Make another loop to the mailbox. 21:51 thing. Make another loop to the mailbox. Make another trip up the stairs. And 21:53 Make another trip up the stairs. And 21:53 Make another trip up the stairs. And here's the thing. If you're that far 21:54 here's the thing. If you're that far 21:54 here's the thing. If you're that far deconditioned, that one thing you add 21:56 deconditioned, that one thing you add 21:56 deconditioned, that one thing you add might need to be added and that's only 21:58 might need to be added and that's only 21:58 might need to be added and that's only extra thing you do for one to two months 22:00 extra thing you do for one to two months 22:00 extra thing you do for one to two months because the reconditioning is much 22:02 because the reconditioning is much 22:02 because the reconditioning is much slower. And then when that becomes 22:04 slower. And then when that becomes 22:04 slower. And then when that becomes normal, then maybe we add a couple more 22:06 normal, then maybe we add a couple more 22:06 normal, then maybe we add a couple more trips up and down the stairs or maybe we 22:08 trips up and down the stairs or maybe we 22:08 trips up and down the stairs or maybe we do other things, right? But it's all 22:10 do other things, right? But it's all 22:10 do other things, right? But it's all baby steps. You I don't care if you were 22:11 baby steps. You I don't care if you were 22:11 baby steps. You I don't care if you were super conditioned and now you're at 25% 22:14 super conditioned and now you're at 25% 22:14 super conditioned and now you're at 25% capacity. If you go back to 100% 22:15 capacity. If you go back to 100% 22:15 capacity. If you go back to 100% capacity of workouts like you did 22:17 capacity of workouts like you did 22:17 capacity of workouts like you did before, you're going to exacerbate your 22:19 before, you're going to exacerbate your 22:19 before, you're going to exacerbate your fatigue and everything else. So, you 22:20 fatigue and everything else. So, you 22:20 fatigue and everything else. So, you want to do baby steps towards 100. If 22:22 want to do baby steps towards 100. If 22:22 want to do baby steps towards 100. If you're totally deconditioned, you're 22:23 you're totally deconditioned, you're 22:23 you're totally deconditioned, you're going to do baby steps towards 22:24 going to do baby steps towards 22:24 going to do baby steps towards something. Well, the actual movement of 22:26 something. Well, the actual movement of 22:26 something. Well, the actual movement of muscle does a number of things. One is 22:28 muscle does a number of things. One is 22:28 muscle does a number of things. One is it changes your biochemistry and your 22:30 it changes your biochemistry and your 22:30 it changes your biochemistry and your signaling so that you have less 22:32 signaling so that you have less 22:32 signaling so that you have less inflammation. Number two, and this is 22:34 inflammation. Number two, and this is 22:34 inflammation. Number two, and this is some newer work done uh early in COVID 22:37 some newer work done uh early in COVID 22:37 some newer work done uh early in COVID where the neurological research has 22:39 where the neurological research has 22:39 where the neurological research has shown that moving the skeletal muscle 22:41 shown that moving the skeletal muscle 22:41 shown that moving the skeletal muscle actually heals the brain inflammation 22:43 actually heals the brain inflammation 22:43 actually heals the brain inflammation that happens. And this brain 22:45 that happens. And this brain 22:45 that happens. And this brain inflammation huge reason for long COVID. 22:47 inflammation huge reason for long COVID. 22:47 inflammation huge reason for long COVID. Diet. Now, we could do hours on diet, 22:50 Diet. Now, we could do hours on diet, 22:50 Diet. Now, we could do hours on diet, etc. But here's the bottom lines of 22:52 etc. But here's the bottom lines of 22:52 etc. But here's the bottom lines of diet. Number one, make sure that the 22:55 diet. Number one, make sure that the 22:55 diet. Number one, make sure that the food that you're eating has the least 22:56 food that you're eating has the least 22:56 food that you're eating has the least amount of added junk to it. Take out 22:59 amount of added junk to it. Take out 22:59 amount of added junk to it. Take out processed foods. Take out convenience 23:01 processed foods. Take out convenience 23:01 processed foods. Take out convenience foods essentially that have a bunch of 23:03 foods essentially that have a bunch of 23:03 foods essentially that have a bunch of additives, eat real food, all of that. 23:06 additives, eat real food, all of that. 23:06 additives, eat real food, all of that. So, the first thing is just take the 23:07 So, the first thing is just take the 23:07 So, the first thing is just take the junk out. The next thing is that we want 23:10 junk out. The next thing is that we want 23:10 junk out. The next thing is that we want to remove empty calories. So, that would 23:13 to remove empty calories. So, that would 23:13 to remove empty calories. So, that would be high sugar drinks or high sugar 23:15 be high sugar drinks or high sugar 23:15 be high sugar drinks or high sugar candies, sweet stuff like that. The next 23:18 candies, sweet stuff like that. The next 23:18 candies, sweet stuff like that. The next thing though is that you want to add in 23:21 thing though is that you want to add in 23:21 thing though is that you want to add in more high fiber plant material because 23:23 more high fiber plant material because 23:23 more high fiber plant material because that's going to help you on a number of 23:25 that's going to help you on a number of 23:25 that's going to help you on a number of levels. So, you're going to add in 23:27 levels. So, you're going to add in 23:27 levels. So, you're going to add in plants, but we want to kind of minimize 23:28 plants, but we want to kind of minimize 23:28 plants, but we want to kind of minimize starchy plants and maximize high fiber 23:31 starchy plants and maximize high fiber 23:31 starchy plants and maximize high fiber plants. You can think of things, you 23:33 plants. You can think of things, you 23:33 plants. You can think of things, you know, like broccoli and cabbage. And 23:35 know, like broccoli and cabbage. And 23:36 know, like broccoli and cabbage. And then the next thing is is that we want a 23:37 then the next thing is is that we want a 23:37 then the next thing is is that we want a low insulinogenic diet. And so, a lot of 23:40 low insulinogenic diet. And so, a lot of 23:40 low insulinogenic diet. And so, a lot of people know, you can look up online a 23:43 people know, you can look up online a 23:43 people know, you can look up online a low glycemic diet and it gives you, you 23:45 low glycemic diet and it gives you, you 23:45 low glycemic diet and it gives you, you know, a list of foods range from low to 23:47 know, a list of foods range from low to 23:47 know, a list of foods range from low to high glycemic. You can also look up low 23:49 high glycemic. You can also look up low 23:49 high glycemic. You can also look up low insulin stimulating foods. But why 23:52 insulin stimulating foods. But why 23:52 insulin stimulating foods. But why insulin? Why do we want to tame insulin? 23:53 insulin? Why do we want to tame insulin? 23:53 insulin? Why do we want to tame insulin? It's because if we can tame insulin in 23:55 It's because if we can tame insulin in 23:55 It's because if we can tame insulin in our diet, then we have less insulin 23:58 our diet, then we have less insulin 23:58 our diet, then we have less insulin being pushed out by our pancreas and we 24:01 being pushed out by our pancreas and we 24:01 being pushed out by our pancreas and we have we lower our inflammation just 24:03 have we lower our inflammation just 24:03 have we lower our inflammation just naturally by doing that. Also, it helps 24:05 naturally by doing that. Also, it helps 24:05 naturally by doing that. Also, it helps the brain, it helps lots of stuff. We 24:07 the brain, it helps lots of stuff. We 24:07 the brain, it helps lots of stuff. We clean up the diet, we add more high 24:09 clean up the diet, we add more high 24:09 clean up the diet, we add more high fiber types of plants, we get a low 24:12 fiber types of plants, we get a low 24:12 fiber types of plants, we get a low insulinogenic diet going on, and then 24:14 insulinogenic diet going on, and then 24:14 insulinogenic diet going on, and then everything after that would be more 24:16 everything after that would be more 24:16 everything after that would be more specific. Things like it certainly if 24:17 specific. Things like it certainly if 24:17 specific. Things like it certainly if you're sensitive to a food, don't eat 24:19 you're sensitive to a food, don't eat 24:19 you're sensitive to a food, don't eat it. If you have a particular way that, 24:21 it. If you have a particular way that, 24:21 it. If you have a particular way that, you know, you eat culturally or 24:23 you know, you eat culturally or 24:23 you know, you eat culturally or traditionally. If you are a vegetarian 24:25 traditionally. If you are a vegetarian 24:25 traditionally. If you are a vegetarian or a vegan or if you eat certain types 24:27 or a vegan or if you eat certain types 24:27 or a vegan or if you eat certain types of like a Mediterranean type eating or 24:29 of like a Mediterranean type eating or 24:29 of like a Mediterranean type eating or whatever. You can morph all of this into 24:31 whatever. You can morph all of this into 24:31 whatever. You can morph all of this into a healthy type of a diet. The diet's 24:33 a healthy type of a diet. The diet's 24:33 a healthy type of a diet. The diet's huge. And then the last thing goes with 24:35 huge. And then the last thing goes with 24:35 huge. And then the last thing goes with diet and that's hydration. Most people 24:37 diet and that's hydration. Most people 24:37 diet and that's hydration. Most people are dehydrated and you think, "Oh, yeah, 24:39 are dehydrated and you think, "Oh, yeah, 24:39 are dehydrated and you think, "Oh, yeah, I drink drink more water, blah, blah, 24:41 I drink drink more water, blah, blah, 24:41 I drink drink more water, blah, blah, blah." There was actually research now 24:42 blah." There was actually research now 24:42 blah." There was actually research now and it's sort of one of those things 24:44 and it's sort of one of those things 24:44 and it's sort of one of those things that's like, "Well, this makes so much 24:45 that's like, "Well, this makes so much 24:45 that's like, "Well, this makes so much sense and why they even research it?" 24:47 sense and why they even research it?" 24:47 sense and why they even research it?" But they did. A lot of it comes from the 24:48 But they did. A lot of it comes from the 24:48 But they did. A lot of it comes from the tumor biology world where if a human is 24:50 tumor biology world where if a human is 24:51 tumor biology world where if a human is dehydrated, then exclusive of all the 24:53 dehydrated, then exclusive of all the 24:53 dehydrated, then exclusive of all the other things with cancer that can go on, 24:55 other things with cancer that can go on, 24:55 other things with cancer that can go on, you don't have as much fluid pushing 24:57 you don't have as much fluid pushing 24:57 you don't have as much fluid pushing into the extracellular space and into 24:59 into the extracellular space and into 24:59 into the extracellular space and into the cell, and that means you don't have 25:01 the cell, and that means you don't have 25:01 the cell, and that means you don't have as much fluid taking the garbage out and 25:03 as much fluid taking the garbage out and 25:03 as much fluid taking the garbage out and putting it back in the venous system to 25:05 putting it back in the venous system to 25:05 putting it back in the venous system to remove it. Well, a lot of cancer 25:07 remove it. Well, a lot of cancer 25:07 remove it. Well, a lot of cancer production in the body is very much 25:10 production in the body is very much 25:10 production in the body is very much sensitive to not taking the trash out of 25:13 sensitive to not taking the trash out of 25:13 sensitive to not taking the trash out of the cell. And so, when you look at this, 25:16 the cell. And so, when you look at this, 25:16 the cell. And so, when you look at this, it doesn't have to be cancer. That can 25:17 it doesn't have to be cancer. That can 25:17 it doesn't have to be cancer. That can be just your whole body's inflamed. The 25:19 be just your whole body's inflamed. The 25:19 be just your whole body's inflamed. The more hydrated you are, the better that 25:22 more hydrated you are, the better that 25:22 more hydrated you are, the better that transfer goes. Now, there's a million 25:23 transfer goes. Now, there's a million 25:23 transfer goes. Now, there's a million other things you can do to those are 25:25 other things you can do to those are 25:25 other things you can do to those are just places to start. The other thing is 25:27 just places to start. The other thing is 25:27 just places to start. The other thing is you you have agency over generally what 25:29 you you have agency over generally what 25:29 you you have agency over generally what you're eating and sleeping and drinking 25:31 you're eating and sleeping and drinking 25:31 you're eating and sleeping and drinking and all of that. But, if you need help, 25:33 and all of that. But, if you need help, 25:33 and all of that. But, if you need help, you can get specific uh counseling in 25:36 you can get specific uh counseling in 25:36 you can get specific uh counseling in those areas. The first thing I want to 25:37 those areas. The first thing I want to 25:37 those areas. The first thing I want to talk about is confusion around long 25:40 talk about is confusion around long 25:40 talk about is confusion around long COVID. So, one of the problems in 25:43 COVID. So, one of the problems in 25:43 COVID. So, one of the problems in looking at the research around long 25:44 looking at the research around long 25:44 looking at the research around long COVID is people present differently. 25:47 COVID is people present differently. 25:47 COVID is people present differently. Now, you can have 10 people with the 25:49 Now, you can have 10 people with the 25:49 Now, you can have 10 people with the same diagnosis of chronic illness, and 25:52 same diagnosis of chronic illness, and 25:52 same diagnosis of chronic illness, and you have 10 different presentations. So, 25:54 you have 10 different presentations. So, 25:54 you have 10 different presentations. So, one of the problems is that this doesn't 25:56 one of the problems is that this doesn't 25:56 one of the problems is that this doesn't lend itself to researching easily 25:59 lend itself to researching easily 25:59 lend itself to researching easily because it's so individualized. So, if I 26:01 because it's so individualized. So, if I 26:01 because it's so individualized. So, if I take a hundred people and the symptoms 26:04 take a hundred people and the symptoms 26:04 take a hundred people and the symptoms are, you know, of 50 different 26:07 are, you know, of 50 different 26:07 are, you know, of 50 different varieties, so different phenotypes of 26:09 varieties, so different phenotypes of 26:09 varieties, so different phenotypes of symptoms, it's harder to drill down and 26:11 symptoms, it's harder to drill down and 26:11 symptoms, it's harder to drill down and say that's what long COVID is or that's 26:14 say that's what long COVID is or that's 26:14 say that's what long COVID is or that's not, right? So, it's very 26:15 not, right? So, it's very 26:15 not, right? So, it's very individualized. The next thing is that 26:18 individualized. The next thing is that 26:18 individualized. The next thing is that for some people it's a fairly shorter 26:20 for some people it's a fairly shorter 26:20 for some people it's a fairly shorter problem, and for some people it's been 26:22 problem, and for some people it's been 26:22 problem, and for some people it's been burning on for, you know, years at this 26:25 burning on for, you know, years at this 26:25 burning on for, you know, years at this point. The other problem that we have is 26:28 point. The other problem that we have is 26:28 point. The other problem that we have is chronic illness before COVID was not 26:30 chronic illness before COVID was not 26:30 chronic illness before COVID was not well treated or understood in the
Research Review on Spikeopathy and Long COVID 26:33 well treated or understood in the 26:33 well treated or understood in the general medical community. And so, long 26:35 general medical community. And so, long 26:35 general medical community. And so, long COVID has just brought a huge number of 26:38 COVID has just brought a huge number of 26:38 COVID has just brought a huge number of patients forward who are also 26:39 patients forward who are also 26:39 patients forward who are also chronically ill into a system that 26:41 chronically ill into a system that 26:41 chronically ill into a system that generally doesn't treat chronic illness 26:43 generally doesn't treat chronic illness 26:43 generally doesn't treat chronic illness very well. So, you can be misunderstood 26:46 very well. So, you can be misunderstood 26:46 very well. So, you can be misunderstood maybe by your primary care or specialty 26:48 maybe by your primary care or specialty 26:48 maybe by your primary care or specialty providers because they weren't really 26:50 providers because they weren't really 26:50 providers because they weren't really treating chronically ill people before 26:53 treating chronically ill people before 26:53 treating chronically ill people before or they didn't know they were. So, 26:54 or they didn't know they were. So, 26:54 or they didn't know they were. So, confusion is a big issue. Also, the 26:57 confusion is a big issue. Also, the 26:57 confusion is a big issue. Also, the biochemical changes and the pathologic 26:59 biochemical changes and the pathologic 26:59 biochemical changes and the pathologic changes at the chemistry level in your 27:01 changes at the chemistry level in your 27:01 changes at the chemistry level in your body that happen with COVID are very 27:04 body that happen with COVID are very 27:04 body that happen with COVID are very unique. And how can they be so unique 27:07 unique. And how can they be so unique 27:07 unique. And how can they be so unique and different? And this is one of the 27:08 and different? And this is one of the 27:08 and different? And this is one of the slams about long COVID you see with some 27:11 slams about long COVID you see with some 27:11 slams about long COVID you see with some commentators will say, "Well, they did 27:12 commentators will say, "Well, they did 27:12 commentators will say, "Well, they did this big research study and they looked 27:14 this big research study and they looked 27:14 this big research study and they looked at all of these, you know, parameters in 27:16 at all of these, you know, parameters in 27:16 at all of these, you know, parameters in the blood in the person biochemically 27:19 the blood in the person biochemically 27:19 the blood in the person biochemically and there's not a pattern. There's not 27:21 and there's not a pattern. There's not 27:21 and there's not a pattern. There's not one thing that goes wrong. So, how do we 27:23 one thing that goes wrong. So, how do we 27:23 one thing that goes wrong. So, how do we call that a disorder if if there's not 27:26 call that a disorder if if there's not 27:26 call that a disorder if if there's not one unifying pattern for the problem? 27:28 one unifying pattern for the problem? 27:28 one unifying pattern for the problem? The biochemical changes and so, you 27:31 The biochemical changes and so, you 27:31 The biochemical changes and so, you might ask yourself and you probably 27:32 might ask yourself and you probably 27:32 might ask yourself and you probably have, how can one insult, let's say an 27:36 have, how can one insult, let's say an 27:36 have, how can one insult, let's say an infection, lead to all these different 27:38 infection, lead to all these different 27:38 infection, lead to all these different manifestations of biochemical change and 27:41 manifestations of biochemical change and 27:41 manifestations of biochemical change and pathology? Well, it's because your 27:44 pathology? Well, it's because your 27:44 pathology? Well, it's because your immune system, when it gets dysregulated 27:46 immune system, when it gets dysregulated 27:46 immune system, when it gets dysregulated or challenged, has multiple potential 27:50 or challenged, has multiple potential 27:50 or challenged, has multiple potential outputs from the challenge. And 27:52 outputs from the challenge. And 27:52 outputs from the challenge. And depending on your health prior, 27:54 depending on your health prior, 27:54 depending on your health prior, depending on underlying diseases or the 27:56 depending on underlying diseases or the 27:56 depending on underlying diseases or the absence of them, depending on certain 27:58 absence of them, depending on certain 27:59 absence of them, depending on certain genomic, genetic factors and all sorts 28:01 genomic, genetic factors and all sorts 28:01 genomic, genetic factors and all sorts of other things, you can have one input 28:04 of other things, you can have one input 28:04 of other things, you can have one input go in and again in 10 people, you can 28:06 go in and again in 10 people, you can 28:06 go in and again in 10 people, you can have 10 different outputs. What does an 28:08 have 10 different outputs. What does an 28:08 have 10 different outputs. What does an immune output look like? It's symptoms 28:11 immune output look like? It's symptoms 28:11 immune output look like? It's symptoms that our body has or sign presentations, 28:14 that our body has or sign presentations, 28:14 that our body has or sign presentations, okay? So, that means I'm not going to 28:16 okay? So, that means I'm not going to 28:16 okay? So, that means I'm not going to have one unifying symptom picture for 28:19 have one unifying symptom picture for 28:19 have one unifying symptom picture for the most part. Now, there are things 28:21 the most part. Now, there are things 28:21 the most part. Now, there are things that are very common such as fatigue, uh 28:24 that are very common such as fatigue, uh 28:24 that are very common such as fatigue, uh brain fog, certain types of uh physical 28:28 brain fog, certain types of uh physical 28:28 brain fog, certain types of uh physical findings and maybe a few other things. 28:30 findings and maybe a few other things. 28:30 findings and maybe a few other things. But a lot of people have very different 28:32 But a lot of people have very different 28:32 But a lot of people have very different uh presentations and manifestations. So, 28:35 uh presentations and manifestations. So, 28:35 uh presentations and manifestations. So, long COVID is a post-viral syndrome that 28:38 long COVID is a post-viral syndrome that 28:38 long COVID is a post-viral syndrome that is in some ways more complex than a lot 28:41 is in some ways more complex than a lot 28:41 is in some ways more complex than a lot of previous post-viral syndromes. So, 28:44 of previous post-viral syndromes. So, 28:44 of previous post-viral syndromes. So, what are the some of the things that can 28:45 what are the some of the things that can 28:46 what are the some of the things that can happen downstream? Well, one is a change 28:48 happen downstream? Well, one is a change 28:48 happen downstream? Well, one is a change in your clotting functions, which can 28:50 in your clotting functions, which can 28:50 in your clotting functions, which can either be short-term or long-term. This 28:53 either be short-term or long-term. This 28:53 either be short-term or long-term. This doesn't sound good, and it's not. So, if 28:55 doesn't sound good, and it's not. So, if 28:55 doesn't sound good, and it's not. So, if I'm having more propensity towards 28:58 I'm having more propensity towards 28:58 I'm having more propensity towards clotting, then I might develop, as we 29:01 clotting, then I might develop, as we 29:01 clotting, then I might develop, as we see in the research coming out now, 29:03 see in the research coming out now, 29:03 see in the research coming out now, micro clotting, okay? Now, obviously, 29:05 micro clotting, okay? Now, obviously, 29:05 micro clotting, okay? Now, obviously, big clots are not a good thing. Micro 29:07 big clots are not a good thing. Micro 29:07 big clots are not a good thing. Micro clotting is just what it says. It's very 29:10 clotting is just what it says. It's very 29:10 clotting is just what it says. It's very small types of clots that can go. And 29:13 small types of clots that can go. And 29:13 small types of clots that can go. And so, they won't stop an organ from 29:15 so, they won't stop an organ from 29:15 so, they won't stop an organ from working, but they may decrease the 29:16 working, but they may decrease the 29:16 working, but they may decrease the functionality of a number of organs in 29:19 functionality of a number of organs in 29:19 functionality of a number of organs in the body. So, clotting changes go on. A 29:21 the body. So, clotting changes go on. A 29:21 the body. So, clotting changes go on. A lot of times in the long COVID 29:23 lot of times in the long COVID 29:23 lot of times in the long COVID population that we see, we look at their 29:25 population that we see, we look at their 29:25 population that we see, we look at their clotting uh laboratory tests, and 29:27 clotting uh laboratory tests, and 29:27 clotting uh laboratory tests, and there's a number of things that you can 29:29 there's a number of things that you can 29:29 there's a number of things that you can look at. But, a lot of times, until 29:31 look at. But, a lot of times, until 29:31 look at. But, a lot of times, until their immune system goes back to being 29:33 their immune system goes back to being 29:33 their immune system goes back to being calmed down, the clotting abnormalities 29:35 calmed down, the clotting abnormalities 29:35 calmed down, the clotting abnormalities we see in the beginning of long COVID 29:37 we see in the beginning of long COVID 29:37 we see in the beginning of long COVID will not go down until the immune system 29:39 will not go down until the immune system 29:39 will not go down until the immune system is calmed down. And that's because 29:41 is calmed down. And that's because 29:41 is calmed down. And that's because clotting is triggered by immune 29:44 clotting is triggered by immune 29:44 clotting is triggered by immune chemistry. Okay, very important to keep 29:46 chemistry. Okay, very important to keep 29:46 chemistry. Okay, very important to keep in mind. So, we often watch those as a 29:48 in mind. So, we often watch those as a 29:48 in mind. So, we often watch those as a sign that we're finally getting ahead in 29:51 sign that we're finally getting ahead in 29:51 sign that we're finally getting ahead in the immune balancing game. So, where 29:53 the immune balancing game. So, where 29:53 the immune balancing game. So, where does this come from? Comes from 29:55 does this come from? Comes from 29:55 does this come from? Comes from deregulation of the immune system. There 29:58 deregulation of the immune system. There 29:58 deregulation of the immune system. There is often found an imbalance in the 30:02 is often found an imbalance in the 30:02 is often found an imbalance in the cell-mediated immunity, the T cell 30:05 cell-mediated immunity, the T cell 30:05 cell-mediated immunity, the T cell families. And so, there are T cells that 30:07 families. And so, there are T cells that 30:07 families. And so, there are T cells that are directly uh cytotoxic, the killer 30:11 are directly uh cytotoxic, the killer 30:11 are directly uh cytotoxic, the killer type T cells, if you will. There are 30:13 type T cells, if you will. There are 30:13 type T cells, if you will. There are memory T cells, and there're helper 30:16 memory T cells, and there're helper 30:16 memory T cells, and there're helper family of T cells. The T help helper 30:18 family of T cells. The T help helper 30:18 family of T cells. The T help helper cells, often called TH, are numerous 30:21 cells, often called TH, are numerous 30:21 cells, often called TH, are numerous subfamilies, and their job is to go and 30:24 subfamilies, and their job is to go and 30:24 subfamilies, and their job is to go and help you when you have this immune 30:26 help you when you have this immune 30:26 help you when you have this immune response to talk to the immune system, 30:29 response to talk to the immune system, 30:29 response to talk to the immune system, so that we have a big response in the 30:31 so that we have a big response in the 30:31 so that we have a big response in the beginning, but then we start to shut it 30:33 beginning, but then we start to shut it 30:33 beginning, but then we start to shut it down and just have immune memory. And 30:35 down and just have immune memory. And 30:35 down and just have immune memory. And that's what happens with T cell 30:36 that's what happens with T cell 30:36 that's what happens with T cell response. They can kind of go off the 30:38 response. They can kind of go off the 30:38 response. They can kind of go off the rails. And when T cell responses go off 30:41 rails. And when T cell responses go off 30:41 rails. And when T cell responses go off the rails, you get either over or under 30:44 the rails, you get either over or under 30:44 the rails, you get either over or under activity downstream in your immune 30:46 activity downstream in your immune 30:46 activity downstream in your immune system, and then that can lead to 30:48 system, and then that can lead to 30:48 system, and then that can lead to increased inflammation, increased 30:50 increased inflammation, increased 30:50 increased inflammation, increased clotting problems, increased pain, all 30:53 clotting problems, increased pain, all 30:53 clotting problems, increased pain, all of these other things. So, an imbalanced 30:55 of these other things. So, an imbalanced 30:55 of these other things. So, an imbalanced T system, especially the T helper 30:57 T system, especially the T helper 30:57 T system, especially the T helper system, is one of the core problems that 30:59 system, is one of the core problems that 30:59 system, is one of the core problems that goes on more at the beginning of your 31:03 goes on more at the beginning of your 31:03 goes on more at the beginning of your physiologic or biochemical changes. 31:06 physiologic or biochemical changes. 31:06 physiologic or biochemical changes. Then, if you look at the way the immune 31:08 Then, if you look at the way the immune 31:08 Then, if you look at the way the immune system works, there's a communication 31:11 system works, there's a communication 31:11 system works, there's a communication between your cell-mediated immunity, 31:13 between your cell-mediated immunity, 31:13 between your cell-mediated immunity, your T cells, and then your humoral or 31:16 your T cells, and then your humoral or 31:16 your T cells, and then your humoral or antibody immunity, the B cells. And if 31:19 antibody immunity, the B cells. And if 31:19 antibody immunity, the B cells. And if we disengage the communication, or if we 31:22 we disengage the communication, or if we 31:22 we disengage the communication, or if we confuse the communication between those 31:24 confuse the communication between those 31:24 confuse the communication between those two big parts of your innate immune 31:26 two big parts of your innate immune 31:26 two big parts of your innate immune system, we get a abnormal output or a 31:30 system, we get a abnormal output or a 31:30 system, we get a abnormal output or a triggering problem in the antibody 31:33 triggering problem in the antibody 31:33 triggering problem in the antibody immunity community as well. And that's 31:36 immunity community as well. And that's 31:36 immunity community as well. And that's going to feed into another pathology 31:38 going to feed into another pathology 31:38 going to feed into another pathology we'll talk about in just a few seconds 31:40 we'll talk about in just a few seconds 31:40 we'll talk about in just a few seconds here. So, the T cells are there for 31:42 here. So, the T cells are there for 31:42 here. So, the T cells are there for cell-mediated immunity, and that's 31:44 cell-mediated immunity, and that's 31:44 cell-mediated immunity, and that's largely the cytotoxic killer type T 31:47 largely the cytotoxic killer type T 31:47 largely the cytotoxic killer type T cells, and then the memory and helper 31:49 cells, and then the memory and helper 31:49 cells, and then the memory and helper families. But then they talk to the the 31:52 families. But then they talk to the the 31:52 families. But then they talk to the the antibody side, and antibodies are going 31:54 antibody side, and antibodies are going 31:54 antibody side, and antibodies are going to be something that comes along and 31:56 to be something that comes along and 31:56 to be something that comes along and binds to a bad guy in your immune system
Assessment and Graded Treatment Approach 31:59 binds to a bad guy in your immune system 31:59 binds to a bad guy in your immune system and tries to alert other parts of the 32:01 and tries to alert other parts of the 32:01 and tries to alert other parts of the immune system to eliminate that bad guy. 32:04 immune system to eliminate that bad guy. 32:04 immune system to eliminate that bad guy. And then of course, your B cells, 32:06 And then of course, your B cells, 32:06 And then of course, your B cells, antibody immunity cells, come in many 32:08 antibody immunity cells, come in many 32:08 antibody immunity cells, come in many different types, and they will make 32:10 different types, and they will make 32:10 different types, and they will make memory against the bad guys. Well, 32:12 memory against the bad guys. Well, 32:12 memory against the bad guys. Well, imagine this is like a giant orchestra, 32:15 imagine this is like a giant orchestra, 32:15 imagine this is like a giant orchestra, and if it all works together, it sounds 32:17 and if it all works together, it sounds 32:17 and if it all works together, it sounds great. If it's not working together, 32:19 great. If it's not working together, 32:19 great. If it's not working together, it's not going to sound very good. And 32:20 it's not going to sound very good. And 32:20 it's not going to sound very good. And that's what happens with your immune 32:22 that's what happens with your immune 32:22 that's what happens with your immune system in long COVID. It can get sort of 32:25 system in long COVID. It can get sort of 32:25 system in long COVID. It can get sort of jumbled, and all of this nice crosstalk 32:27 jumbled, and all of this nice crosstalk 32:27 jumbled, and all of this nice crosstalk and feedback goes out the window. So, 32:30 and feedback goes out the window. So, 32:30 and feedback goes out the window. So, the T and the B cells are doing their 32:32 the T and the B cells are doing their 32:32 the T and the B cells are doing their job, and then they get confused in their 32:34 job, and then they get confused in their 32:34 job, and then they get confused in their job, and then we have downstream 32:36 job, and then we have downstream 32:36 job, and then we have downstream problems. So, what are some of the 32:39 problems. So, what are some of the 32:39 problems. So, what are some of the problems? Well, the biggest problem 32:41 problems? Well, the biggest problem 32:41 problems? Well, the biggest problem underneath is global inflammation in the 32:44 underneath is global inflammation in the 32:44 underneath is global inflammation in the body, and that can then lead downstream 32:47 body, and that can then lead downstream 32:47 body, and that can then lead downstream to inflammatory changes in your big 32:49 to inflammatory changes in your big 32:50 to inflammatory changes in your big organ systems. So, your brain, your 32:52 organ systems. So, your brain, your 32:52 organ systems. So, your brain, your lungs, your kidneys, your heart, all 32:54 lungs, your kidneys, your heart, all 32:54 lungs, your kidneys, your heart, all over your muscles, you know, all over 32:56 over your muscles, you know, all over 32:56 over your muscles, you know, all over your body. Digestive tract can be 32:58 your body. Digestive tract can be 32:58 your body. Digestive tract can be inflamed as well. As we said, the 33:00 inflamed as well. As we said, the 33:00 inflamed as well. As we said, the inflammation, the inflammatory chemistry 33:02 inflammation, the inflammatory chemistry 33:02 inflammation, the inflammatory chemistry in your immune system can lead to big 33:05 in your immune system can lead to big 33:05 in your immune system can lead to big clots or little micro clots, which have 33:07 clots or little micro clots, which have 33:07 clots or little micro clots, which have their own problems. The other thing that 33:09 their own problems. The other thing that 33:09 their own problems. The other thing that is getting a little bit more notice now 33:11 is getting a little bit more notice now 33:11 is getting a little bit more notice now is COVID often opens the door through 33:14 is COVID often opens the door through 33:14 is COVID often opens the door through this immune dysregulation to chronic 33:17 this immune dysregulation to chronic 33:17 this immune dysregulation to chronic coinfections that either you might have 33:19 coinfections that either you might have 33:19 coinfections that either you might have before, and and we have we all have a 33:21 before, and and we have we all have a 33:21 before, and and we have we all have a lot of infectious material in our body 33:23 lot of infectious material in our body 33:23 lot of infectious material in our body that just hangs out that's not making us 33:25 that just hangs out that's not making us 33:25 that just hangs out that's not making us sick. But if we get run down, could 33:27 sick. But if we get run down, could 33:27 sick. But if we get run down, could happen with the flu, too, or pneumonia 33:29 happen with the flu, too, or pneumonia 33:29 happen with the flu, too, or pneumonia or something. But with COVID, often you 33:31 or something. But with COVID, often you 33:31 or something. But with COVID, often you get run down, you mess up the immune 33:33 get run down, you mess up the immune 33:33 get run down, you mess up the immune system's response, then these little 33:35 system's response, then these little 33:35 system's response, then these little infections that weren't a problem before 33:37 infections that weren't a problem before 33:37 infections that weren't a problem before now are are infecting us on top of the 33:40 now are are infecting us on top of the 33:40 now are are infecting us on top of the COVID. So, a lot of times in our long 33:41 COVID. So, a lot of times in our long 33:41 COVID. So, a lot of times in our long COVID population, we will screen people 33:44 COVID population, we will screen people 33:44 COVID population, we will screen people for chronic infections because they are 33:46 for chronic infections because they are 33:46 for chronic infections because they are almost always there. Problem is, they're 33:48 almost always there. Problem is, they're 33:48 almost always there. Problem is, they're not always the same thing because the 33:51 not always the same thing because the 33:51 not always the same thing because the immune dysregulation that happens for 33:53 immune dysregulation that happens for 33:53 immune dysregulation that happens for one group of people might increase 33:55 one group of people might increase 33:55 one group of people might increase viruses like Epstein-Barr or something. 33:57 viruses like Epstein-Barr or something. 33:57 viruses like Epstein-Barr or something. And in other group of people, it might 33:59 And in other group of people, it might 33:59 And in other group of people, it might be more fungal problems. Resistant 34:01 be more fungal problems. Resistant 34:01 be more fungal problems. Resistant fungal problems are on the rise. Or 34:03 fungal problems are on the rise. Or 34:03 fungal problems are on the rise. Or other issues that go on. And another big 34:06 other issues that go on. And another big 34:06 other issues that go on. And another big picture problem that often, if you had 34:08 picture problem that often, if you had 34:08 picture problem that often, if you had it before, might get way worse, but a 34:10 it before, might get way worse, but a 34:10 it before, might get way worse, but a lot of people didn't have it before and 34:12 lot of people didn't have it before and 34:12 lot of people didn't have it before and now they do in long COVID, is mast cell 34:14 now they do in long COVID, is mast cell 34:14 now they do in long COVID, is mast cell disorder. So, you've heard about mast 34:16 disorder. So, you've heard about mast 34:16 disorder. So, you've heard about mast cell activation syndrome, MCAS, or mast 34:20 cell activation syndrome, MCAS, or mast 34:20 cell activation syndrome, MCAS, or mast cell disease, mast cell disorders. These 34:23 cell disease, mast cell disorders. These 34:23 cell disease, mast cell disorders. These used to be thought to be extremely rare. 34:25 used to be thought to be extremely rare. 34:25 used to be thought to be extremely rare. Even before COVID, we knew that they 34:27 Even before COVID, we knew that they 34:27 Even before COVID, we knew that they weren't as rare as we thought they were. 34:29 weren't as rare as we thought they were. 34:29 weren't as rare as we thought they were. It's very hard to diagnose in some 34:31 It's very hard to diagnose in some 34:31 It's very hard to diagnose in some cases. Mass cells are part of a 34:33 cases. Mass cells are part of a 34:33 cases. Mass cells are part of a four-part activation system that 34:36 four-part activation system that 34:36 four-part activation system that includes mass cells and then basophils 34:40 includes mass cells and then basophils 34:40 includes mass cells and then basophils and eosinophils and then a another 34:42 and eosinophils and then a another 34:42 and eosinophils and then a another subclass of cell called CD40 that are 34:45 subclass of cell called CD40 that are 34:45 subclass of cell called CD40 that are triggering one of the B cell 34:47 triggering one of the B cell 34:47 triggering one of the B cell populations, the IgE like Edward, which 34:49 populations, the IgE like Edward, which 34:49 populations, the IgE like Edward, which is we think of for allergy and you know, 34:52 is we think of for allergy and you know, 34:52 is we think of for allergy and you know, anaphylaxis and things but also is part 34:54 anaphylaxis and things but also is part 34:54 anaphylaxis and things but also is part of the mass cell quartet there. Well, it 34:57 of the mass cell quartet there. Well, it 34:58 of the mass cell quartet there. Well, it turns out that the COVID experience can 35:00 turns out that the COVID experience can 35:00 turns out that the COVID experience can deregulate your immune system so you 35:02 deregulate your immune system so you 35:02 deregulate your immune system so you become hypersensitive and the mass cell 35:05 become hypersensitive and the mass cell 35:05 become hypersensitive and the mass cell quartet, so it's mass cells plus the 35:08 quartet, so it's mass cells plus the 35:08 quartet, so it's mass cells plus the other three, start to pump out immune 35:10 other three, start to pump out immune 35:10 other three, start to pump out immune information that you don't want, very 35:12 information that you don't want, very 35:12 information that you don't want, very inflammatory, very dysregulating to your 35:15 inflammatory, very dysregulating to your 35:15 inflammatory, very dysregulating to your system. That's a real common 35:17 system. That's a real common 35:17 system. That's a real common complicating factor in long COVID. So, 35:20 complicating factor in long COVID. So, 35:20 complicating factor in long COVID. So, what do we do about this? It's nice to 35:22 what do we do about this? It's nice to 35:22 what do we do about this? It's nice to maybe know the underlying complexity of 35:25 maybe know the underlying complexity of 35:25 maybe know the underlying complexity of it. The first thing that you want to 35:26 it. The first thing that you want to 35:26 it. The first thing that you want to think about is some people, and if 35:29 think about is some people, and if 35:29 think about is some people, and if you're having great luck with a long 35:31 you're having great luck with a long 35:31 you're having great luck with a long COVID clinic, please keep going there. 35:33 COVID clinic, please keep going there. 35:33 COVID clinic, please keep going there. You know, people are getting help at 35:34 You know, people are getting help at 35:34 You know, people are getting help at some of those. But if you've been 35:35 some of those. But if you've been 35:36 some of those. But if you've been checked out and they basically said, 35:37 checked out and they basically said, 35:37 checked out and they basically said, "Look, your organs are fine." Well, 35:39 "Look, your organs are fine." Well, 35:39 "Look, your organs are fine." Well, great. That's really wonderful and maybe 35:41 great. That's really wonderful and maybe 35:41 great. That's really wonderful and maybe they offer some symptomatic treatment or 35:43 they offer some symptomatic treatment or 35:43 they offer some symptomatic treatment or they don't, depends on the long COVID 35:45 they don't, depends on the long COVID 35:45 they don't, depends on the long COVID clinic. What we find is usually if that 35:47 clinic. What we find is usually if that 35:47 clinic. What we find is usually if that approach is not cutting it, you need to 35:49 approach is not cutting it, you need to 35:50 approach is not cutting it, you need to find an integrative practitioner. There 35:52 find an integrative practitioner. There 35:52 find an integrative practitioner. There are more and more integrative health 35:53 are more and more integrative health 35:53 are more and more integrative health practitioners in the world and even if 35:56 practitioners in the world and even if 35:56 practitioners in the world and even if they weren't doing a lot of chronic 35:58 they weren't doing a lot of chronic 35:58 they weren't doing a lot of chronic illness things before with long COVID, 36:01 illness things before with long COVID, 36:01 illness things before with long COVID, they're seeing more of them. They're 36:02 they're seeing more of them. They're 36:02 they're seeing more of them. They're just more likely to take a step back and 36:04 just more likely to take a step back and 36:04 just more likely to take a step back and look more in a whole body, you know, 36:06 look more in a whole body, you know, 36:06 look more in a whole body, you know, kind of systems approach to what's going 36:08 kind of systems approach to what's going 36:08 kind of systems approach to what's going wrong with you as opposed to a specialty 36:11 wrong with you as opposed to a specialty 36:11 wrong with you as opposed to a specialty approach where you start with the organ 36:13 approach where you start with the organ 36:13 approach where you start with the organ system and dive, you know, deeper. Both 36:15 system and dive, you know, deeper. Both 36:15 system and dive, you know, deeper. Both are necessary, but a systems approach is 36:17 are necessary, but a systems approach is 36:17 are necessary, but a systems approach is probably better for long chronic 36:20 probably better for long chronic 36:20 probably better for long chronic illness. So, looking for integrated 36:22 illness. So, looking for integrated 36:22 illness. So, looking for integrated practitioners, that might be a 36:24 practitioners, that might be a 36:24 practitioners, that might be a physician, nurse practitioner, 36:26 physician, nurse practitioner, 36:26 physician, nurse practitioner, physician's assistant, You might see a 36:29 physician's assistant, You might see a 36:29 physician's assistant, You might see a uh acupuncture oriental medicine person 36:31 uh acupuncture oriental medicine person 36:31 uh acupuncture oriental medicine person who has specialized in long COVID. There 36:33 who has specialized in long COVID. There 36:33 who has specialized in long COVID. There are some chiropractic physicians and 36:36 are some chiropractic physicians and 36:36 are some chiropractic physicians and other types of physicians that work 36:38 other types of physicians that work 36:38 other types of physicians that work there. Licensed naturopathic physicians 36:40 there. Licensed naturopathic physicians 36:40 there. Licensed naturopathic physicians do a really good job with this in many 36:42 do a really good job with this in many 36:42 do a really good job with this in many cases and other integrated 36:44 cases and other integrated 36:44 cases and other integrated practitioners. So, having somebody so 36:46 practitioners. So, having somebody so 36:46 practitioners. So, having somebody so they can they may not need to do 36:48 they can they may not need to do 36:48 they can they may not need to do everything with you, but they can kind 36:50 everything with you, but they can kind 36:50 everything with you, but they can kind of give that macro look and guide thing. 36:53 of give that macro look and guide thing. 36:53 of give that macro look and guide thing. going to mention some therapies that 36:55 going to mention some therapies that 36:55 going to mention some therapies that people try and and first we need to 36:58 people try and and first we need to 36:58 people try and and first we need to remember this is not medical advice. I'm 37:00 remember this is not medical advice. I'm 37:01 remember this is not medical advice. I'm just giving what I've seen other people 37:03 just giving what I've seen other people 37:03 just giving what I've seen other people do and people might consider. One that 37:06 do and people might consider. One that 37:06 do and people might consider. One that sounds unusual, but it's because of 37:08 sounds unusual, but it's because of 37:08 sounds unusual, but it's because of receptor binding that people have done 37:10 receptor binding that people have done 37:10 receptor binding that people have done is nicotine therapy. So, a lot of people 37:13 is nicotine therapy. So, a lot of people 37:13 is nicotine therapy. So, a lot of people use low-dose nicotine patches and that 37:15 use low-dose nicotine patches and that 37:15 use low-dose nicotine patches and that can be quite helpful because nicotine 37:19 can be quite helpful because nicotine 37:19 can be quite helpful because nicotine the receptors that it binds to are not 37:21 the receptors that it binds to are not 37:21 the receptors that it binds to are not only in your brain, but elsewhere in 37:23 only in your brain, but elsewhere in 37:23 only in your brain, but elsewhere in your body. You have to be very careful 37:25 your body. You have to be very careful 37:25 your body. You have to be very careful with nicotine therapy because especially 37:27 with nicotine therapy because especially 37:27 with nicotine therapy because especially if your body isn't used to nicotine, 37:29 if your body isn't used to nicotine, 37:29 if your body isn't used to nicotine, it's very easy to overdose on nicotine 37:31 it's very easy to overdose on nicotine 37:31 it's very easy to overdose on nicotine and so you really want to do that with 37:33 and so you really want to do that with 37:33 and so you really want to do that with some guidance, but nicotine therapy is 37:36 some guidance, but nicotine therapy is 37:36 some guidance, but nicotine therapy is on the rise and helping a lot of people. 37:38 on the rise and helping a lot of people. 37:38 on the rise and helping a lot of people. Things that go and help your 37:39 Things that go and help your 37:39 Things that go and help your mitochondria, which are where we make 37:41 mitochondria, which are where we make 37:41 mitochondria, which are where we make our energy and it helps us recharge our 37:44 our energy and it helps us recharge our 37:44 our energy and it helps us recharge our body. Some therapies like NAD therapy, 37:47 body. Some therapies like NAD therapy, 37:47 body. Some therapies like NAD therapy, that is a common type of approach for 37:50 that is a common type of approach for 37:50 that is a common type of approach for mitochondrial support. There are oral 37:52 mitochondrial support. There are oral 37:52 mitochondrial support. There are oral therapies like nicotinamide riboside or 37:55 therapies like nicotinamide riboside or 37:55 therapies like nicotinamide riboside or nicotinamide mononucleotide that can be 37:57 nicotinamide mononucleotide that can be 37:57 nicotinamide mononucleotide that can be done. There's IV therapies, other things 38:00 done. There's IV therapies, other things 38:00 done. There's IV therapies, other things that goes directly to your mitochondria 38:02 that goes directly to your mitochondria 38:02 that goes directly to your mitochondria to help. Another one that goes to your 38:03 to help. Another one that goes to your 38:03 to help. Another one that goes to your mitochondria that we're seeing more on, 38:04 mitochondria that we're seeing more on, 38:04 mitochondria that we're seeing more on, we got a bunch of videos on all these is 38:06 we got a bunch of videos on all these is 38:07 we got a bunch of videos on all these is methylene blue, which is the oldest 38:09 methylene blue, which is the oldest 38:09 methylene blue, which is the oldest synthetic drug that we have at least in 38:12 synthetic drug that we have at least in 38:12 synthetic drug that we have at least in medical history. It's a dye, but it also 38:15 medical history. It's a dye, but it also 38:15 medical history. It's a dye, but it also is used if you have a pharmaceutical 38:18 is used if you have a pharmaceutical 38:18 is used if you have a pharmaceutical grade to go into your body and help the 38:20 grade to go into your body and help the 38:20 grade to go into your body and help the mitochondria kind of kick back in. Now, 38:22 mitochondria kind of kick back in. Now, 38:23 mitochondria kind of kick back in. Now, it helps your whole body, but we've seen 38:25 it helps your whole body, but we've seen 38:25 it helps your whole body, but we've seen a lot of benefit in people, especially 38:27 a lot of benefit in people, especially 38:27 a lot of benefit in people, especially where they have neurological symptoms of 38:30 where they have neurological symptoms of 38:30 where they have neurological symptoms of long COVID. So, that's something to keep 38:32 long COVID. So, that's something to keep 38:32 long COVID. So, that's something to keep in mind as well. Another one that I've 38:34 in mind as well. Another one that I've 38:34 in mind as well. Another one that I've had a lot of people do at home is red 38:36 had a lot of people do at home is red 38:37 had a lot of people do at home is red light or red light near infrared pad 38:39 light or red light near infrared pad 38:39 light or red light near infrared pad therapy. We use a lot with people with 38:41 therapy. We use a lot with people with 38:41 therapy. We use a lot with people with specific organ areas. So, that'd be a 38:44 specific organ areas. So, that'd be a 38:44 specific organ areas. So, that'd be a pelvic dysfunction, uh chest and lung, 38:47 pelvic dysfunction, uh chest and lung, 38:47 pelvic dysfunction, uh chest and lung, etc. Again, these are things that you 38:49 etc. Again, these are things that you 38:49 etc. Again, these are things that you can often get and and do as at-home 38:51 can often get and and do as at-home 38:51 can often get and and do as at-home therapies. Again, work with your 38:53 therapies. Again, work with your 38:53 therapies. Again, work with your practitioner on that. Sauna and heat 38:55 practitioner on that. Sauna and heat 38:55 practitioner on that. Sauna and heat therapies, you may not tolerate it, so 38:57 therapies, you may not tolerate it, so 38:57 therapies, you may not tolerate it, so work with your practitioner on that. 38:59 work with your practitioner on that. 38:59 work with your practitioner on that. But, sauna can be incredibly good. 39:01 But, sauna can be incredibly good. 39:01 But, sauna can be incredibly good. Usually, you start really tiny and work 39:03 Usually, you start really tiny and work 39:03 Usually, you start really tiny and work your way up dose-wise. Hyperbaric oxygen 39:06 your way up dose-wise. Hyperbaric oxygen 39:06 your way up dose-wise. Hyperbaric oxygen is another one that really helps. 39:07 is another one that really helps. 39:07 is another one that really helps. There's some big universities that are 39:08 There's some big universities that are 39:09 There's some big universities that are doing trials on hyperbaric. And there's 39:11 doing trials on hyperbaric. And there's 39:11 doing trials on hyperbaric. And there's actually some hyperbaric research that's 39:12 actually some hyperbaric research that's 39:13 actually some hyperbaric research that's come out during COVID that's compelling. 39:15 come out during COVID that's compelling. 39:15 come out during COVID that's compelling. And then all sorts of other things that 39:16 And then all sorts of other things that 39:16 And then all sorts of other things that can just be supportive to the body, uh 39:19 can just be supportive to the body, uh 39:19 can just be supportive to the body, uh such as nutritional therapies, dietary 39:22 such as nutritional therapies, dietary 39:22 such as nutritional therapies, dietary adjustments, etc. Now, keep in mind this 39:24 adjustments, etc. Now, keep in mind this 39:24 adjustments, etc. Now, keep in mind this isn't medical advice, this is what we 39:26 isn't medical advice, this is what we 39:26 isn't medical advice, this is what we see in patients. And you need to 39:27 see in patients. And you need to 39:27 see in patients. And you need to remember not everyone can do these. You 39:29 remember not everyone can do these. You 39:29 remember not everyone can do these. You certainly generally wouldn't do all of 39:31 certainly generally wouldn't do all of 39:31 certainly generally wouldn't do all of them, but sometimes it's finding like 39:33 them, but sometimes it's finding like 39:33 them, but sometimes it's finding like the the two or three keys to go into the 39:36 the the two or three keys to go into the 39:36 the the two or three keys to go into the two or three locks that are your 39:37 two or three locks that are your 39:37 two or three locks that are your particular part of the problem with long 39:40 particular part of the problem with long 39:40 particular part of the problem with long COVID. And once you find them, then your 39:42 COVID. And once you find them, then your 39:42 COVID. And once you find them, then your body can be supported and you can kind 39:44 body can be supported and you can kind 39:44 body can be supported and you can kind of unwind the problem that started. 39:52 I wanted to take a couple of minutes and 39:52 I wanted to take a couple of minutes and go over a new publication that reviews 39:55 go over a new publication that reviews 39:55 go over a new publication that reviews 139 peer-reviewed scientific references 39:59 139 peer-reviewed scientific references 39:59 139 peer-reviewed scientific references and goes through both the background, 40:02 and goes through both the background, 40:02 and goes through both the background, the assessment, and then the treatment 40:04 the assessment, and then the treatment 40:04 the assessment, and then the treatment of people with both long COVID and 40:07 of people with both long COVID and 40:07 of people with both long COVID and spikeopathies, which we'll talk about in 40:09 spikeopathies, which we'll talk about in 40:09 spikeopathies, which we'll talk about in just a moment. First off, this is a 40:11 just a moment. First off, this is a 40:12 just a moment. First off, this is a review that I published last month, so 40:14 review that I published last month, so 40:15 review that I published last month, so it is very recent and new. And as I said 40:17 it is very recent and new. And as I said 40:17 it is very recent and new. And as I said in going through this to try and gather 40:20 in going through this to try and gather 40:20 in going through this to try and gather all of the latest science with this very 40:22 all of the latest science with this very 40:22 all of the latest science with this very emerging problem, I went through 139 40:25 emerging problem, I went through 139 40:26 emerging problem, I went through 139 peer-reviewed references from the 40:27 peer-reviewed references from the 40:27 peer-reviewed references from the scientific literature and merged that 40:29 scientific literature and merged that 40:29 scientific literature and merged that with my own and others personal clinical 40:32 with my own and others personal clinical 40:32 with my own and others personal clinical experience and came up with a systematic 40:36 experience and came up with a systematic 40:36 experience and came up with a systematic discussion and treatment algorithm for 40:39 discussion and treatment algorithm for 40:39 discussion and treatment algorithm for long COVID and spikeopathies. So, the 40:42 long COVID and spikeopathies. So, the 40:42 long COVID and spikeopathies. So, the first thing is long COVID and spike 40:45 first thing is long COVID and spike 40:45 first thing is long COVID and spike protein damage have a lot of crossover. 40:48 protein damage have a lot of crossover. 40:48 protein damage have a lot of crossover. So, as we know, we can get spike and 40:51 So, as we know, we can get spike and 40:51 So, as we know, we can get spike and spike increases in the body from a COVID 40:53 spike increases in the body from a COVID 40:53 spike increases in the body from a COVID infection. We can get spike and spike 40:56 infection. We can get spike and spike 40:56 infection. We can get spike and spike increases from vax. We can get them from 40:59 increases from vax. We can get them from 40:59 increases from vax. We can get them from both together. One of the common cores 41:02 both together. One of the common cores 41:02 both together. One of the common cores is the damage that the spike protein can 41:05 is the damage that the spike protein can 41:05 is the damage that the spike protein can possibly do, and that can be primary 41:08 possibly do, and that can be primary 41:08 possibly do, and that can be primary damage such as restrictive pulmonary 41:11 damage such as restrictive pulmonary 41:11 damage such as restrictive pulmonary disease, inflammatory disease of the 41:13 disease, inflammatory disease of the 41:13 disease, inflammatory disease of the heart or the kidneys, etc. brain 41:15 heart or the kidneys, etc. brain 41:15 heart or the kidneys, etc. brain dysfunctions, secondary things such as 41:18 dysfunctions, secondary things such as 41:18 dysfunctions, secondary things such as cytokine reactions, and all manner of 41:21 cytokine reactions, and all manner of 41:21 cytokine reactions, and all manner of other disruptions, and then also 41:23 other disruptions, and then also 41:23 other disruptions, and then also aggravation of pre-existing conditions 41:26 aggravation of pre-existing conditions 41:26 aggravation of pre-existing conditions that go on. So, what we look at in this 41:28 that go on. So, what we look at in this 41:28 that go on. So, what we look at in this review is in the first part, we go 41:32 review is in the first part, we go 41:32 review is in the first part, we go through the science and the data that 41:34 through the science and the data that 41:34 through the science and the data that talks about what do we know as far as 41:36 talks about what do we know as far as 41:36 talks about what do we know as far as what comes from the post-infectious 41:39 what comes from the post-infectious 41:39 what comes from the post-infectious era. So, you had an infection with 41:42 era. So, you had an infection with 41:42 era. So, you had an infection with COVID, now you have these signs and 41:45 COVID, now you have these signs and 41:45 COVID, now you have these signs and symptoms. What do we know about the 41:47 symptoms. What do we know about the 41:47 symptoms. What do we know about the relationship of your COVID infection to 41:49 relationship of your COVID infection to 41:49 relationship of your COVID infection to those signs and symptoms? And then also, 41:51 those signs and symptoms? And then also, 41:51 those signs and symptoms? And then also, either alone or with a COVID infection, 41:54 either alone or with a COVID infection, 41:54 either alone or with a COVID infection, we look at what are the spikeopathies 41:57 we look at what are the spikeopathies 41:57 we look at what are the spikeopathies that are potentially possible based on 41:59 that are potentially possible based on 41:59 that are potentially possible based on the current research that we have 42:00 the current research that we have 42:00 the current research that we have available for vax and vax injury 42:03 available for vax and vax injury 42:03 available for vax and vax injury potentially. And also, we look at the 42:06 potentially. And also, we look at the 42:06 potentially. And also, we look at the collage effect of what if we have both 42:08 collage effect of what if we have both 42:08 collage effect of what if we have both things going on. So, we look at all of 42:10 things going on. So, we look at all of 42:10 things going on. So, we look at all of the data behind that. That's all in the 42:12 the data behind that. That's all in the 42:12 the data behind that. That's all in the beginning in the introduction. We look 42:14 beginning in the introduction. We look 42:14 beginning in the introduction. We look at the possibilities for different types 42:17 at the possibilities for different types 42:17 at the possibilities for different types of collateral health problems that may 42:19 of collateral health problems that may 42:19 of collateral health problems that may come from one or both of those triggers 42:21 come from one or both of those triggers 42:21 come from one or both of those triggers for these problems. And we look at what 42:23 for these problems. And we look at what 42:23 for these problems. And we look at what the research says about what we know 42:25 the research says about what we know 42:25 the research says about what we know about them to date. The next thing that 42:27 about them to date. The next thing that 42:27 about them to date. The next thing that we look at are ways to test to see 42:30 we look at are ways to test to see 42:30 we look at are ways to test to see indirectly at this moment anyway, what 42:33 indirectly at this moment anyway, what 42:33 indirectly at this moment anyway, what the spike protein load 42:35 the spike protein load 42:35 the spike protein load on the immune system is. And we look at 42:37 on the immune system is. And we look at 42:37 on the immune system is. And we look at ways that are based on the research to 42:39 ways that are based on the research to 42:40 ways that are based on the research to say, is that load more likely from the 42:42 say, is that load more likely from the 42:42 say, is that load more likely from the COVID infection itself, or is that load 42:45 COVID infection itself, or is that load 42:45 COVID infection itself, or is that load more likely from the vax, or a little 42:48 more likely from the vax, or a little 42:48 more likely from the vax, or a little bit of both? And there are ways using 42:50 bit of both? And there are ways using 42:51 bit of both? And there are ways using immunologic tests that not only look at 42:53 immunologic tests that not only look at 42:53 immunologic tests that not only look at spike effect, but also the presence or 42:55 spike effect, but also the presence or 42:55 spike effect, but also the presence or absence of the nucleocapsid or N 42:58 absence of the nucleocapsid or N 42:58 absence of the nucleocapsid or N protein, which we can then use to 43:00 protein, which we can then use to 43:00 protein, which we can then use to decipher is this more likely coming from 43:02 decipher is this more likely coming from 43:02 decipher is this more likely coming from the infectious trigger or a 43:05 the infectious trigger or a 43:05 the infectious trigger or a non-infectious trigger. So, all of that 43:07 non-infectious trigger. So, all of that 43:07 non-infectious trigger. So, all of that is gone through in the very beginning of 43:09 is gone through in the very beginning of 43:09 is gone through in the very beginning of the article, and it goes into some depth 43:11 the article, and it goes into some depth 43:11 the article, and it goes into some depth because there's been a lot of conjecture 43:13 because there's been a lot of conjecture 43:13 because there's been a lot of conjecture and a lot of interesting proposed ideas 43:16 and a lot of interesting proposed ideas 43:16 and a lot of interesting proposed ideas out there in the world. And what I was 43:18 out there in the world. And what I was 43:18 out there in the world. And what I was trying to do is get through the 43:19 trying to do is get through the 43:19 trying to do is get through the conjecture and look at the science and 43:21 conjecture and look at the science and 43:21 conjecture and look at the science and look at the published data and see, 43:23 look at the published data and see, 43:23 look at the published data and see, well, what do we really know from what's 43:25 well, what do we really know from what's 43:25 well, what do we really know from what's been published up to this point? And it 43:27 been published up to this point? And it 43:27 been published up to this point? And it would take us probably an hour to go 43:29 would take us probably an hour to go 43:29 would take us probably an hour to go through all of that. So, we're going to 43:30 through all of that. So, we're going to 43:31 through all of that. So, we're going to put a link in the description below to 43:33 put a link in the description below to 43:33 put a link in the description below to the article. You can go through there 43:35 the article. You can go through there 43:35 the article. You can go through there and take a read if you want to. Now, 43:37 and take a read if you want to. Now, 43:37 and take a read if you want to. Now, this is on a public access web server. 43:40 this is on a public access web server. 43:40 this is on a public access web server. And so, if you're not a member of the 43:42 And so, if you're not a member of the 43:42 And so, if you're not a member of the particular site, there's no charge. You 43:44 particular site, there's no charge. You 43:45 particular site, there's no charge. You just log in as a guest, and it will take 43:47 just log in as a guest, and it will take 43:47 just log in as a guest, and it will take you right to this publication. So, the 43:49 you right to this publication. So, the 43:49 you right to this publication. So, the next thing is, what is a rational way 43:53 next thing is, what is a rational way 43:53 next thing is, what is a rational way that I and others who work with this 43:56 that I and others who work with this 43:56 that I and others who work with this clinically have found to approach 43:59 clinically have found to approach 43:59 clinically have found to approach people, regardless of where the 44:00 people, regardless of where the 44:00 people, regardless of where the spikeopathy came from, whether from 44:03 spikeopathy came from, whether from 44:03 spikeopathy came from, whether from post-infectious illness or vax-induced 44:06 post-infectious illness or vax-induced 44:06 post-infectious illness or vax-induced spikeopathy or a little bit of both. At 44:08 spikeopathy or a little bit of both. At 44:08 spikeopathy or a little bit of both. At the point where you're sick, it doesn't 44:10 the point where you're sick, it doesn't 44:10 the point where you're sick, it doesn't matter as much because we have to do 44:12 matter as much because we have to do 44:12 matter as much because we have to do something about that. So, what does the 44:14 something about that. So, what does the 44:14 something about that. So, what does the research tell us about ways to look at 44:16 research tell us about ways to look at 44:16 research tell us about ways to look at and assess and then potentially treat 44:18 and assess and then potentially treat 44:18 and assess and then potentially treat patients? And what does my and others' 44:20 patients? And what does my and others' 44:20 patients? And what does my and others' experience tell us about ways to assess 44:23 experience tell us about ways to assess 44:23 experience tell us about ways to assess and potentially treat these patients? 44:25 and potentially treat these patients? 44:25 and potentially treat these patients? So, in the paper, in the second 2/3 of 44:28 So, in the paper, in the second 2/3 of 44:28 So, in the paper, in the second 2/3 of the paper, again relying heavily on 44:30 the paper, again relying heavily on 44:30 the paper, again relying heavily on current research plus all of the 44:32 current research plus all of the 44:32 current research plus all of the clinical experience of myself and 44:34 clinical experience of myself and 44:34 clinical experience of myself and others, what we go through is a graded 44:38 others, what we go through is a graded 44:38 others, what we go through is a graded dysfunction-based assessment. And while 44:41 dysfunction-based assessment. And while 44:41 dysfunction-based assessment. And while there are a couple of published ways to 44:44 there are a couple of published ways to 44:44 there are a couple of published ways to assess post-COVID illness, long COVID, 44:47 assess post-COVID illness, long COVID, 44:47 assess post-COVID illness, long COVID, whatever you'd like to call it, what I 44:49 whatever you'd like to call it, what I 44:49 whatever you'd like to call it, what I have used all through since we started 44:51 have used all through since we started 44:52 have used all through since we started getting people with post-infectious 44:54 getting people with post-infectious 44:54 getting people with post-infectious illness, etc., is a particular rating 44:56 illness, etc., is a particular rating 44:56 illness, etc., is a particular rating scale by Clock et al. And that is listed 45:00 scale by Clock et al. And that is listed 45:00 scale by Clock et al. And that is listed in the paper as well. It's very simple 45:02 in the paper as well. It's very simple 45:02 in the paper as well. It's very simple rating scale, but it has a five-part 45:05 rating scale, but it has a five-part 45:05 rating scale, but it has a five-part rating, zero being no real problems, one 45:08 rating, zero being no real problems, one 45:08 rating, zero being no real problems, one being mild disability, and all the way 45:10 being mild disability, and all the way 45:11 being mild disability, and all the way up through four being severe disability. 45:13 up through four being severe disability. 45:13 up through four being severe disability. And what we know in the spikeopathy, 45:17 And what we know in the spikeopathy, 45:17 And what we know in the spikeopathy, long COVID, post-COVID world is that 45:19 long COVID, post-COVID world is that 45:19 long COVID, post-COVID world is that some people are not affected, obviously. 45:22 some people are not affected, obviously. 45:22 some people are not affected, obviously. Some people are mildly affected, and 45:24 Some people are mildly affected, and 45:24 Some people are mildly affected, and some people are very extremely affected, 45:26 some people are very extremely affected, 45:26 some people are very extremely affected, and we have everything in between. So, 45:28 and we have everything in between. So, 45:28 and we have everything in between. So, based on the research, we have a way of 45:30 based on the research, we have a way of 45:30 based on the research, we have a way of assessing people, and you can actually 45:33 assessing people, and you can actually 45:33 assessing people, and you can actually take a look in the paper and see the 45:35 take a look in the paper and see the 45:35 take a look in the paper and see the level of dysfunction and disorder 45:37 level of dysfunction and disorder 45:37 level of dysfunction and disorder disease, and you can see it's pretty 45:39 disease, and you can see it's pretty 45:39 disease, and you can see it's pretty easy to categorize into one of those, 45:42 easy to categorize into one of those, 45:42 easy to categorize into one of those, especially four pathologic categories. 45:45 especially four pathologic categories. 45:45 especially four pathologic categories. Now, why would we do this? The reason is 45:48 Now, why would we do this? The reason is 45:48 Now, why would we do this? The reason is that, like any complex chronic illness, 45:51 that, like any complex chronic illness, 45:51 that, like any complex chronic illness, post-COVID issues, spikeopathies, long 45:54 post-COVID issues, spikeopathies, long 45:54 post-COVID issues, spikeopathies, long COVID, whatever we're calling it, have a 45:57 COVID, whatever we're calling it, have a 45:57 COVID, whatever we're calling it, have a lot of potential laboratory 45:59 lot of potential laboratory 45:59 lot of potential laboratory investigations that may need to be done, 46:02 investigations that may need to be done, 46:02 investigations that may need to be done, examinations that may need to be done, 46:04 examinations that may need to be done, 46:04 examinations that may need to be done, history that needs to be taken, and even 46:07 history that needs to be taken, and even 46:07 history that needs to be taken, and even imaging and other types of studies that 46:09 imaging and other types of studies that 46:09 imaging and other types of studies that need to be done. And sometimes people 46:11 need to be done. And sometimes people 46:11 need to be done. And sometimes people will come to other practitioners, and 46:13 will come to other practitioners, and 46:13 will come to other practitioners, and they will have had pieces of the workup 46:15 they will have had pieces of the workup 46:15 they will have had pieces of the workup done, but maybe not everything they 46:17 done, but maybe not everything they 46:17 done, but maybe not everything they need. But to help the practitioners 46:19 need. But to help the practitioners 46:19 need. But to help the practitioners prioritize by using this validated scale 46:23 prioritize by using this validated scale 46:23 prioritize by using this validated scale from the medical research, if you are at 46:26 from the medical research, if you are at 46:26 from the medical research, if you are at a grade one, we're going to do some 46:28 a grade one, we're going to do some 46:28 a grade one, we're going to do some basic laboratory tests, etc., that are 46:31 basic laboratory tests, etc., that are 46:31 basic laboratory tests, etc., that are appropriate to that level of 46:32 appropriate to that level of 46:32 appropriate to that level of dysfunction, but they're going to be 46:34 dysfunction, but they're going to be 46:34 dysfunction, but they're going to be very different than the list of things 46:36 very different than the list of things 46:36 very different than the list of things we're going to consider at a grade three 46:38 we're going to consider at a grade three 46:38 we're going to consider at a grade three or a grade four. And that's because the 46:40 or a grade four. And that's because the 46:40 or a grade four. And that's because the level of dysfunction is completely 46:42 level of dysfunction is completely 46:42 level of dysfunction is completely different. Now, everybody essentially 46:44 different. Now, everybody essentially 46:44 different. Now, everybody essentially gets the same basic testing algorithm, 46:47 gets the same basic testing algorithm, 46:47 gets the same basic testing algorithm, and then things are added on as there is 46:49 and then things are added on as there is 46:49 and then things are added on as there is a higher level of dysfunction. That's 46:52 a higher level of dysfunction. That's 46:52 a higher level of dysfunction. That's just the way that it works. So, this 46:54 just the way that it works. So, this 46:54 just the way that it works. So, this helps to save from testing in things 46:56 helps to save from testing in things 46:56 helps to save from testing in things that you don't need, but also to give 46:59 that you don't need, but also to give 46:59 that you don't need, but also to give ideas to you and your practitioners as 47:01 ideas to you and your practitioners as 47:01 ideas to you and your practitioners as to what should we include if I'm still 47:03 to what should we include if I'm still 47:03 to what should we include if I'm still at a heavier level of illness or 47:06 at a heavier level of illness or 47:06 at a heavier level of illness or disability. So, that's the reason for 47:08 disability. So, that's the reason for 47:08 disability. So, that's the reason for using a graded approach. So, the first 47:10 using a graded approach. So, the first 47:10 using a graded approach. So, the first part of the graded approach is what's 47:12 part of the graded approach is what's 47:12 part of the graded approach is what's the assessment, what grade are you in as 47:14 the assessment, what grade are you in as 47:14 the assessment, what grade are you in as far as dysfunction, etc., and then what 47:17 far as dysfunction, etc., and then what 47:17 far as dysfunction, etc., and then what kind of testing and other stuff do we 47:19 kind of testing and other stuff do we 47:19 kind of testing and other stuff do we need to do. Then the next part is to 47:22 need to do. Then the next part is to 47:22 need to do. Then the next part is to look at the therapeutics that are 47:24 look at the therapeutics that are 47:24 look at the therapeutics that are appropriate for that level of disability 47:27 appropriate for that level of disability 47:27 appropriate for that level of disability and disease state. So, if you are in a 47:31 and disease state. So, if you are in a 47:31 and disease state. So, if you are in a grade one, the level of therapeutics you 47:34 grade one, the level of therapeutics you 47:34 grade one, the level of therapeutics you need might come from a broad list that 47:36 need might come from a broad list that 47:36 need might come from a broad list that you can pick from to see what works 47:37 you can pick from to see what works 47:38 you can pick from to see what works best, but it may be less intense than 47:40 best, but it may be less intense than 47:40 best, but it may be less intense than somebody who's a grade three or four 47:42 somebody who's a grade three or four 47:42 somebody who's a grade three or four needs, which is usually the case. And 47:45 needs, which is usually the case. And 47:45 needs, which is usually the case. And the people who have the most intense 47:47 the people who have the most intense 47:47 the people who have the most intense sort of experience and progressive 47:50 sort of experience and progressive 47:50 sort of experience and progressive disability, etc., usually are going to 47:52 disability, etc., usually are going to 47:52 disability, etc., usually are going to wind up being a grade three or grade 47:54 wind up being a grade three or grade 47:54 wind up being a grade three or grade four. They're going to have a lot more 47:56 four. They're going to have a lot more 47:56 four. They're going to have a lot more options as far as what might be needed 47:58 options as far as what might be needed 47:58 options as far as what might be needed to be tested and treated. Regardless of 48:02 to be tested and treated. Regardless of 48:02 to be tested and treated. Regardless of where you are in that spectrum of 48:04 where you are in that spectrum of 48:04 where you are in that spectrum of disability and disease as far as long 48:07 disability and disease as far as long 48:07 disability and disease as far as long COVID post COVID spikeopathy, we're 48:09 COVID post COVID spikeopathy, we're 48:09 COVID post COVID spikeopathy, we're going to look at what we can do in the 48:12 going to look at what we can do in the 48:12 going to look at what we can do in the following areas. So, one is to identify 48:16 following areas. So, one is to identify 48:16 following areas. So, one is to identify and treat comorbid conditions. So, this 48:18 and treat comorbid conditions. So, this 48:18 and treat comorbid conditions. So, this might be something you already knew 48:19 might be something you already knew 48:20 might be something you already knew about. You had a thyroid problem or 48:22 about. You had a thyroid problem or 48:22 about. You had a thyroid problem or hormone imbalance or blood sugar 48:24 hormone imbalance or blood sugar 48:24 hormone imbalance or blood sugar problem. Maybe you already knew you had 48:26 problem. Maybe you already knew you had 48:26 problem. Maybe you already knew you had Epstein-Barr virus or some other chronic 48:28 Epstein-Barr virus or some other chronic 48:28 Epstein-Barr virus or some other chronic thing. Long COVID spikeopathies, etc. 48:31 thing. Long COVID spikeopathies, etc. 48:31 thing. Long COVID spikeopathies, etc. can make all of that worse. So, our idea 48:33 can make all of that worse. So, our idea 48:33 can make all of that worse. So, our idea is we need to treat the rest of you. The 48:35 is we need to treat the rest of you. The 48:35 is we need to treat the rest of you. The other thing is that there's a lot of 48:37 other thing is that there's a lot of 48:37 other thing is that there's a lot of research showing that you can get a 48:40 research showing that you can get a 48:40 research showing that you can get a person who didn't have any trouble with 48:42 person who didn't have any trouble with 48:42 person who didn't have any trouble with Epstein-Barr and just picking on that as 48:44 Epstein-Barr and just picking on that as 48:44 Epstein-Barr and just picking on that as one example. And after you start 48:46 one example. And after you start 48:46 one example. And after you start treating that person, you'll find out 48:49 treating that person, you'll find out 48:49 treating that person, you'll find out that the the spike protein, the 48:51 that the the spike protein, the 48:51 that the the spike protein, the spikeopathy, wherever it came from, is 48:54 spikeopathy, wherever it came from, is 48:54 spikeopathy, wherever it came from, is reactivating those types of virus. So, 48:56 reactivating those types of virus. So, 48:56 reactivating those types of virus. So, they have to be treated at the same 48:57 they have to be treated at the same 48:57 they have to be treated at the same time. Just one of many examples. The 49:00 time. Just one of many examples. The 49:00 time. Just one of many examples. The next thing, which is very critical, is 49:02 next thing, which is very critical, is 49:02 next thing, which is very critical, is to support coagulation and clotting 49:04 to support coagulation and clotting 49:04 to support coagulation and clotting issues that are going on. It's almost 49:07 issues that are going on. It's almost 49:07 issues that are going on. It's almost universal that people with any level of 49:09 universal that people with any level of 49:09 universal that people with any level of spikeopathy are going to have an 49:12 spikeopathy are going to have an 49:12 spikeopathy are going to have an increased potential towards clotting. 49:14 increased potential towards clotting. 49:14 increased potential towards clotting. And we want to take a look at potentials 49:16 And we want to take a look at potentials 49:16 And we want to take a look at potentials for clotting and either just be doing 49:19 for clotting and either just be doing 49:19 for clotting and either just be doing some preventive things that are very 49:21 some preventive things that are very 49:21 some preventive things that are very global or even doing some clotting 49:23 global or even doing some clotting 49:23 global or even doing some clotting assessment and maybe doing some direct 49:25 assessment and maybe doing some direct 49:25 assessment and maybe doing some direct treatments. And all of those things are 49:27 treatments. And all of those things are 49:27 treatments. And all of those things are listed in the algorithm in the 49:29 listed in the algorithm in the 49:29 listed in the algorithm in the publication. The next two areas that are 49:32 publication. The next two areas that are 49:32 publication. The next two areas that are critical is to potentially block the 49:36 critical is to potentially block the 49:36 critical is to potentially block the spike protein from entering cells and 49:38 spike protein from entering cells and 49:38 spike protein from entering cells and then degrade the spike protein that's 49:40 then degrade the spike protein that's 49:40 then degrade the spike protein that's there. One of the problems that we see 49:43 there. One of the problems that we see 49:43 there. One of the problems that we see now in the research and we see it 49:45 now in the research and we see it 49:45 now in the research and we see it clinically is spikeopathies that tend to 49:47 clinically is spikeopathies that tend to 49:47 clinically is spikeopathies that tend to be from treatment as opposed to 49:49 be from treatment as opposed to 49:49 be from treatment as opposed to infection can continue to produce spike 49:52 infection can continue to produce spike 49:52 infection can continue to produce spike protein we now know over 200 days after 49:56 protein we now know over 200 days after 49:56 protein we now know over 200 days after the treatment was given. And so we not 49:58 the treatment was given. And so we not 49:58 the treatment was given. And so we not only need to look at spike protein 50:00 only need to look at spike protein 50:00 only need to look at spike protein impact on the immune system, but we need 50:02 impact on the immune system, but we need 50:03 impact on the immune system, but we need to do treatments to both break it down 50:05 to do treatments to both break it down 50:05 to do treatments to both break it down and block it from entering. And again, 50:07 and block it from entering. And again, 50:07 and block it from entering. And again, those agents are listed in the review as 50:10 those agents are listed in the review as 50:10 those agents are listed in the review as well. The other thing that is universal 50:12 well. The other thing that is universal 50:12 well. The other thing that is universal with COVID either during the acute COVID 50:14 with COVID either during the acute COVID 50:14 with COVID either during the acute COVID infection or the post-COVID spikeopathy 50:17 infection or the post-COVID spikeopathy 50:17 infection or the post-COVID spikeopathy period is it causes a lot of immune 50:20 period is it causes a lot of immune 50:21 period is it causes a lot of immune dysregulation, immune imbalance. And as 50:24 dysregulation, immune imbalance. And as 50:24 dysregulation, immune imbalance. And as we go along, immune imbalance has to be 50:27 we go along, immune imbalance has to be 50:27 we go along, immune imbalance has to be addressed and treated so that we have an 50:30 addressed and treated so that we have an 50:30 addressed and treated so that we have an easier time of our body getting back 50:32 easier time of our body getting back 50:32 easier time of our body getting back into a healing state. So when we address 50:35 into a healing state. So when we address 50:35 into a healing state. So when we address and we treat the rest of the problems 50:37 and we treat the rest of the problems 50:37 and we treat the rest of the problems going on, we need to remember that the 50:39 going on, we need to remember that the 50:39 going on, we need to remember that the immune system has to be addressed so 50:41 immune system has to be addressed so 50:41 immune system has to be addressed so it's not getting too over or 50:43 it's not getting too over or 50:43 it's not getting too over or under-stimulated. And that's something 50:45 under-stimulated. And that's something 50:45 under-stimulated. And that's something that is spoken about in the review as 50:47 that is spoken about in the review as 50:47 that is spoken about in the review as well. Antioxidant nutrient status, we 50:50 well. Antioxidant nutrient status, we 50:50 well. Antioxidant nutrient status, we take a big hit in the area of just our 50:52 take a big hit in the area of just our 50:52 take a big hit in the area of just our general nutrients, but also antioxidant 50:55 general nutrients, but also antioxidant 50:55 general nutrients, but also antioxidant nutrients in the body. And usually those 50:57 nutrients in the body. And usually those 50:57 nutrients in the body. And usually those don't go totally away or you wouldn't be 51:00 don't go totally away or you wouldn't be 51:00 don't go totally away or you wouldn't be here, but they can get depleted through 51:02 here, but they can get depleted through 51:02 here, but they can get depleted through the process. And so we want to make sure 51:04 the process. And so we want to make sure 51:04 the process. And so we want to make sure that we have support for that going on. 51:07 that we have support for that going on. 51:07 that we have support for that going on. And then a universal need is the support 51:10 And then a universal need is the support 51:10 And then a universal need is the support of mitochondrial function. And this is 51:12 of mitochondrial function. And this is 51:12 of mitochondrial function. And this is something that certainly is a range of 51:14 something that certainly is a range of 51:14 something that certainly is a range of thing. We have a ton of mitochondrial 51:17 thing. We have a ton of mitochondrial 51:17 thing. We have a ton of mitochondrial information on the YouTube site here, 51:18 information on the YouTube site here, 51:19 information on the YouTube site here, but we have this big range of 51:21 but we have this big range of 51:21 but we have this big range of dysfunction that can go from primary 51:23 dysfunction that can go from primary 51:23 dysfunction that can go from primary mitochondrial inherited illness to 51:26 mitochondrial inherited illness to 51:26 mitochondrial inherited illness to functional mitochondrial illness to 51:28 functional mitochondrial illness to 51:28 functional mitochondrial illness to simply disease associated mitochondrial 51:30 simply disease associated mitochondrial 51:30 simply disease associated mitochondrial dysfunction, meaning it's not an 51:32 dysfunction, meaning it's not an 51:32 dysfunction, meaning it's not an inherited disease or anything, but your 51:34 inherited disease or anything, but your 51:34 inherited disease or anything, but your mitochondria which produce all the 51:36 mitochondria which produce all the 51:36 mitochondria which produce all the energy in your body are still not 51:37 energy in your body are still not 51:37 energy in your body are still not working the way that they used to. So 51:40 working the way that they used to. So 51:40 working the way that they used to. So we're going to need to at some point, 51:42 we're going to need to at some point, 51:42 we're going to need to at some point, maybe from the beginning, maybe a little 51:44 maybe from the beginning, maybe a little 51:44 maybe from the beginning, maybe a little later as as heal up, address the level 51:47 later as as heal up, address the level 51:47 later as as heal up, address the level of mitochondrial function and it might 51:49 of mitochondrial function and it might 51:49 of mitochondrial function and it might need to be supported through the 51:50 need to be supported through the 51:51 need to be supported through the process. And then the last thing 51:52 process. And then the last thing 51:52 process. And then the last thing discussed in the paper is really 51:55 discussed in the paper is really 51:55 discussed in the paper is really timelines and expectations for timing of 51:57 timelines and expectations for timing of 51:58 timelines and expectations for timing of healing, etc. So, when we think about 52:01 healing, etc. So, when we think about 52:01 healing, etc. So, when we think about this, it is somewhat, in my personal 52:03 this, it is somewhat, in my personal 52:03 this, it is somewhat, in my personal experience, analogous to the initial 52:06 experience, analogous to the initial 52:06 experience, analogous to the initial disability and disease assessment that 52:08 disability and disease assessment that 52:08 disability and disease assessment that we're going to do. So, you kind of have 52:10 we're going to do. So, you kind of have 52:10 we're going to do. So, you kind of have lower-grade and higher-grade problems. 52:12 lower-grade and higher-grade problems. 52:12 lower-grade and higher-grade problems. Lower-grade problems usually are going 52:14 Lower-grade problems usually are going 52:14 Lower-grade problems usually are going to resolve more quickly. Higher-grade 52:16 to resolve more quickly. Higher-grade 52:16 to resolve more quickly. Higher-grade problems are going to take a longer time 52:19 problems are going to take a longer time 52:19 problems are going to take a longer time to resolve. And so, we give some 52:21 to resolve. And so, we give some 52:21 to resolve. And so, we give some guidelines around the amount of time 52:23 guidelines around the amount of time 52:23 guidelines around the amount of time that on average people are taking to not 52:26 that on average people are taking to not 52:26 that on average people are taking to not only go through the process, but to 52:28 only go through the process, but to 52:28 only go through the process, but to implement the healing strategies. So, 52:30 implement the healing strategies. So, 52:30 implement the healing strategies. So, again, what we're going to do here in 52:32 again, what we're going to do here in 52:32 again, what we're going to do here in the description box below is put a link 52:35 the description box below is put a link 52:35 the description box below is put a link to this paper. It's a free link. If you 52:38 to this paper. It's a free link. If you 52:38 to this paper. It's a free link. If you go to the site and you're not a member, 52:40 go to the site and you're not a member, 52:40 go to the site and you're not a member, you can sign in as a guest. You don't 52:42 you can sign in as a guest. You don't 52:43 you can sign in as a guest. You don't need to be a subscriber. You can sign in 52:44 need to be a subscriber. You can sign in 52:44 need to be a subscriber. You can sign in as a guest, and you'll get free access 52:46 as a guest, and you'll get free access 52:46 as a guest, and you'll get free access to the paper. And again, it's a number 52:48 to the paper. And again, it's a number 52:48 to the paper. And again, it's a number of pages long and it has 139 52:51 of pages long and it has 139 52:51 of pages long and it has 139 peer-reviewed references that are cited 52:54 peer-reviewed references that are cited 52:54 peer-reviewed references that are cited and related to what we're saying in the 52:56 and related to what we're saying in the 52:56 and related to what we're saying in the paper, and also related to what we're 52:58 paper, and also related to what we're 52:58 paper, and also related to what we're saying about assessment and treatment 53:01 saying about assessment and treatment 53:01 saying about assessment and treatment for people in anywhere in the spectrum 53:03 for people in anywhere in the spectrum 53:03 for people in anywhere in the spectrum of post-COVID, long-COVID, spikeopathy, 53:05 of post-COVID, long-COVID, spikeopathy, 53:05 of post-COVID, long-COVID, spikeopathy, etc. Really glad that we were able to 53:08 etc. Really glad that we were able to 53:08 etc. Really glad that we were able to get this paper out. It's been able to 53:10 get this paper out. It's been able to 53:10 get this paper out. It's been able to help a lot of clinicians work their way 53:12 help a lot of clinicians work their way 53:12 help a lot of clinicians work their way through this very complex problem that 53:14 through this very complex problem that 53:14 through this very complex problem that people are having. And it is open 53:16 people are having. And it is open 53:16 people are having. And it is open access. I wanted to get it out and make 53:19 access. I wanted to get it out and make 53:19 access. I wanted to get it out and make it published that way, so it was easy to 53:20 it published that way, so it was easy to 53:20 it published that way, so it was easy to get by anybody who wanted it. And it is 53:23 get by anybody who wanted it. And it is 53:23 get by anybody who wanted it. And it is free for access for you, your 53:26 free for access for you, your 53:26 free for access for you, your clinicians, anybody who's interested. 53:28 clinicians, anybody who's interested. 53:28 clinicians, anybody who's interested. Thank you very much. Please do 53:30 Thank you very much. Please do 53:30 Thank you very much. Please do subscribe, like, share, do all the 53:32 subscribe, like, share, do all the 53:32 subscribe, like, share, do all the things. We love that the community is 53:34 things. We love that the community is 53:34 things. We love that the community is growing here. Check out the link below, 53:36 growing here. Check out the link below, 53:36 growing here. Check out the link below, and we'll put some other video links up 53:38 and we'll put some other video links up 53:38 and we'll put some other video links up here for you as well. Thank you very 53:40 here for you as well. Thank you very 53:40 here for you as well. Thank you very much.
Comments